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Vitamin B12 is an essential nutrient in human dietary, as it has an important role in 
promoting carbohydrate and normal fat metabolism, as well as it is essential in the 
formation of red blood cells, and the normal functioning of the nervous system. 
Naturally occurring vitamin B12 is found mainly in animal-based foods (meat, milk 
and eggs), but it is well-known for its absence in plants and fruits. A couple of plant-
based foods such as particular types of dried lavers (nori) and certain species of 
mushrooms contain certain amounts of vitamin B12. Actinorhizal plants, such as 
Hippophae rhamnoides are symbiotic with actinobacteria Frankia alni, they are 
potential producers of vitamin B12. Due to modern vegetarian and vegan nutrition in 
the last decades, more and more attention has been paid to natural vitamin B12 
sources of plant origin. Based on increased demands of strict vegetarians for more 
plant-sourced vitamin B12 and due to the high risk of vitamin B12 deficiency in certain 
risk groups, an investigation of vitamin B12 content in plant sources was carried out.  
 
An extraction protocol based on previous non-plant methods for the isolation and 
purification of vitamin B12, was optimized and specialized for plant matrices. 
Afterwards the analysis was performed with a developed and validated high 
performance liquid chromatographic method HPLC–UV for the determination of 
vitamin B12 (cyanocobalamin), and a high performance liquid chromatographic 
method HPLC–MS/MS for the determination of cyanocobalamin analogues. The 
method was successfully applied to several plant samples and extracts, Hippophae 
rhamnoides juice and vitamin B12 tablets in comparison to animal based systems 
(veal liver).  
 
The vitamin B12 concentration was determined by RP-HPLC with UV detection and 
the active vitamin B12 was separated from pseudo-vitamin B12 by an HPLC–MS/MS 
method, after prior matrix isolation by immunoaffinity chromatography (IAC). 
Vitamin B12 was extracted from plants and berries in the presence of sodium 
cyanide, to transform all forms of cobalamin into cyanocobalamin. A diode array 
detector (DAD) was used to monitor vitamin B12, after its chromatographic 
separation under gradient elution with a mobile phase consisting of acetonitrile and 
trifluoroacetic acid (TFA) 0.025 % (w/v). The method demonstrated linear response 
over a large range of concentrations with a regression coefficient r
2
> 0.999. LOD and 
LOQ values were 0.004 μg/ ml and 0.014 μg/ ml, respectively. The system precision 
of the method was evaluated at different concentration levels and the relative 
standard deviation for standard solutions of cobalamin ranged from 0.53 – 7.37 %, 
for plant samples the precision varies between 0.7 and 0.8 % (n=6). The specificity of 
the method was demonstrated by the retention characteristics, UV spectra and by 
comparing the peak purity with an external standard solution. Significant amounts of 




weight), in Inula helenium (11 μg/ 100 g dry weight), in Agropyron repens (26 – 23 
μg/ 100 g) and trace amounts in black mustard (1.52 μg/ 100 g).  
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Vitamin B12 ist ein essentieller Nährstoff in der menschlichen Ernährung, der eine 
wichtige Rolle in dem Kohlenhydrat- und normalen Fettmetabolismus spielt. 
Desweiteren ist es auch essentiell bei der Bildung roter Blutkörperchen und der 
Normalfunktion des Nervensystems beteiligt. Natürlich vorkommendes Vitamin B12 
wird hauptsächlich in tierischen Lebensmitteln (Fleisch, Milch und Eiern) gefunden, 
jedoch nicht in Pflanzen und Früchten. Einige pflanzenbasierte Lebensmittel, wie 
spezielle Typen getrockneten Seetangs (nori), sowie bestimmte Arten von Pilzen 
enthalten eine geringe Menge an Vitamin B12. Aktinorrhiza-Pflanzen, wie Hippophae 
rhamnoides, bilden eine Symbiose mit den Actinobakterien Frankia alni, und sind 
potentielle Erzeuger von Vitamin B12. Auf Grund moderner vegetarischer und 
veganer Ernährung in den letzten Jahrzehnten, wird mehr und mehr Aufmerksamkeit 
auf natürliche Vitamin B12 Quellen pflanzlichen Ursprungs gerichtet. Basierend auf 
der steigenden Nachfrage strikter Vegetarier nach mehr pflanzenlichem Vitamin B12, 
sowie dem hohen Risiko an Vitamin B12-Mangel in bestimmten Risikogruppen, wurde 
eine Untersuchung des Vitamin B12-Gehalts aus pflanzlichen Quellen durchgeführt. 
 
Ein auf nicht-pflanzlichen Methoden basierendes Extraktionsprotokoll zur Isolierung 
und Reinigung von Vitamin B12 wurde für Pflanzenmatrizen optimiert und 
spezialisiert. Die anschließende Analyse wurde mit einer entwickelten und 
validierten Hochleistungsflüssigkeitschromatographiemethode HPLC für die 
Bestimmung von Vitamin B12 (Cyanocobalamin) durchgeführt. Um Cyano-
cobalaminanaloge zu bestimmen wurde eine Hochleistungsflüssigkeitschromato-
graphiemethode gekoppelt mit einer Massenspektrometrie HPLC-MS/MS 
verwendet. Die Methode konnte erfolgreich auf verschiedene Pflanzenproben und 
Extrakten, Hippophae rhamnoides Saft und Vitamin B12-Tabletten im Vergleich zu 
tierisch basierten Systemen (Kalbsleber) angewendet werden. 
 
Anschließend an eine Matrix Isolation durch Immunaffinitätschromatographie (IAC) 
wurde die Vitamin B12-Konzentration mittels RP-HPLC mit UV-Detektion bestimmt 
und das aktive Vitamin B12 wurde durch eine HPLC-MS/MS Methode von dem 
Pseudo-Vitamin B12 getrennt. Vitamin B12 wurde aus Pflanzen und Früchten in der 
Gegenwart von Natriumcyanid extrahiert, um alle Formen von Cobalamin zu 
Cyanocobalamin zu transformieren. Nach einer chromatographischen Trennung mit 
Hilfe einer Gradietenelution mit einer mobile Phase bestehend aus Acetonritil und 
0,025 % (w/v) Trifluoressigsäure (TFA), wurde ein Diodenarray-Detektor (DAD) 
genutzt, um Vitamin B12 zu detektieren. Die Methode zeigte Linearität über einen 
großen Konzentrationsbereich mit einem Regressionskoeffizienten r²> 0,999. Die 
LOD und LOQ Werte betrugen 0,004 µg/ml und 0,014 µg/ml. Die Systempräzision der 
Methode wurde bei verschiedenen Konzentrationen evaluiert und die relative 




Verfahrens wurde durch die Retentionseigenschaften, UV-Spektren und den 
Vergleich der Peakreinheit mit einem externen Standard nachgewiesen. Signifikante 
Mengen von Vitamin B12 konnten in den Pflanzen Hippophae rhamnoides (37 μg/ 100 
g Trockengewicht), in Inula helenium (11 μg/ 100 g Trockengewicht), in Agropyron 
repens (26 – 23 μg/ 100 g) und Spuren in schwarzem Senf (1.52 μg/ 100 g) detektiert 
werden. 
 
Stichwörter: vitamin B12 (cobalamin), pflanzenbasierte Lebensmittel, Hippophae 
rhamnoides, Frankia alni, Extraktionsprotokoll, Immunaffinitätschromatographie 
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In the developed world consumers are increasingly health conscious and aware of 
their nutritional requirements. At the same time, in the developing world 
malnutrition can result in dietary deficiencies, particularly in vitamins, lack of 




Malnutrition based diseases such as pernicious anemia, which was first described in 
1824 had fatal prognosis, prior to the discovery of its treatment. It took about one 
hundred years before Whipple, Minot and Murphy discovered that after treatment 
ith li e  …all the patie ts sho ed a pu tual, apid, a d disti t e issio  of their 
a e ia…  a d that li e  ust o tai  a  a ti-pernicious anemia factor2. In this 
period that can be described as the early medicinal era of vitamin B12 Whipple, 
Minot and Murphy in 1934 shared the Nobel Prize for Medicine and Physiology. 
Folkers at Merck, Sharp and Dohme and, soon afterwards, Smith at Glaxo, after the 
Second World War, isolated and crystallized that factor, which was named vitamin 
B12
2
. Dorothy Hodgkin was awarded the Nobel Prize in Chemistry in 1964 for using  
X-ray crystallography to determine its structure
3
. In 1972, Woodward and 
Eschenmoser reported the total synthesis of vitamin B12 as a result of a collaborative 
effort involving more than one hundred scientists over eleven years
4,5
. During the 
vitamin B12 crystallographical age (1948 – 1985) the chemistry of vitamin B12 
upsurged, until the crystal structure determination of several B12-dependent 
enzymes which play an important role in vitamin B12 enzymology
6,7,8
. Finally, the 
structure of transcobalamin (TC)
9
 has provided the structural basis for designing 
appropriate Cbl-based bioconjugates for imaging of tumours as well as targeted and 




Vitamin B12 belongs to a group of strictly related compounds called corrinoids. All 
corrinoids (including all cobalamins) are considered B12 analogues. Many corrinoids, 
and possibly even some cobalamins, are not useable by human vitamin B12 enzymes. 
These are considered inactive vitamin B12 analogues. Different forms of vitamin B12 
are similar in the Co central ion, the four parts of the corrin ring and a 
dimethylbenzimidazole group, but differ in the sixth site which may contain a cyano 
group (–CN), hydroxyl group (–OH), methyl group (–CH3) and/or a 5' deoxyadenosyl 
group (–Ado)11; It is the only water-soluble vitamin that can be stored in the liver for 
many years
12
. The biological active forms of vitamin B12 are methylcobalamin and 
adenosylcobalamin. However, the synthetic cyanocobalamin, as the most stable 
form of vitamin B12, is the form mainly used in pharmaceuticals, supplements and in 
the fortification of foods. Cyanocobalamin is converted in human metabolism to the 








Vitamin B12 is acting as a co-enzyme and plays an important role in promoting 
carbohydrate, protein and normal fat metabolism, it is essential in the formation of 
red blood cells, the normal functioning of the nervous system and on the 
translocation of the methyl group in DNA synthesis
14,15,16
. Although vitamin B12 
deficiency in developed countries is uncommon and unlikely to develop in healthy 
human beings (except in strict vegetarians), studies have shown that deficiency may 
lead to megaloblasts (i.e., abnormal cell growth that results in anemia); symptoms 
include excessive tiredness, listlessness, breathlessness, and poor resistance to 
infections. Extended deficiency leads to nerve degeneration and irreversible 
neurological damage. Causes of deficiency may comprise nutritional imbalance 
(among vegetarians), malabsorption syndromes and other gastrointestinal 
problems
17
. According to the Institute of Medicine (National Academies, USA), the 
recommended daily allowance (RDA) for the vitamin B12 is 2.4 μg/ d18. Vegeterians 
are at higher risk of vitamin B12 deficiency than non-vegetarians
19
. The deficiency 
frequency among vegetarians were estimated as 62 % in pregnant women, 25 – 86 % 
in children, 21 – 41 % in adolescents, and 11 – 90 % in elderly subjects, by review of 




Cobalamin is unique, in a sense of its de novo synthesis, production appears to be 
restricted only to some bacteria and archea. These vitamin B12-producing 
microorganisms form the biological source of vitamin B12. Cobalamin provides a 
nutritional requirement for animals and protists although they do not synthesize it, 
whereas plants, neither require nor synthesize it
1
. There is evidence that nitrogen 
fixing actinobacteria Frankia alni produce the vitamin B12 and these bacteria form 
nodule endophytes in woody trees and shrubs. Frankia alni is symbiotic with 
actinorhizal plants (comprising of eight families and 25 genera, and containing more 
than 220 species)
21
. Owing to this symbiosis, content of vitamin B12 is possible to be 
found also in plants
22
. Therefore, the vitamin is found in foods fermented by such 
bacteria, in plants symbiotic with Frankia alni, or derived from the tissues of animals 
which have ingested B12-containing foods. Likewise, ruminant animals can obtain 
cobalamin from certain bacteria in their microflora which synthesize the vitamin, and 
consequently the liver of such animals is a rich source of this specific vitamin. 
Actinorhizal plants such as Hippophae rhammnoides and Myrica which are symbiotic 





Major sources of vitamim B12 are liver, meat, milk, eggs, fish, oysters and clams. 
Although vitamin B12 is well-known for its absence in plant source foods (apart from 
plants that have been contaminated with soil or have been exposed to foods 
containing vitamin B12
24,25
), edible species of mushrooms including black trumpet 





noticeable amounts of vitamin B12 (1.09 – 2.65 μg/ 100 g dry weight), in comparison 
with other species of wild mushrooms that contain no vitamin B12 or trace amounts. 
The corrinoids of these mushrooms have been identified as vitamin B12
26,27
. On the 
other hand, certain species of edible cyanobacteria such as Spirulina, 
Aphanizomenon and Nostoc contain significant amounts of vitamin B12 analogues 
(pseudo-B12) which are known to be biologically inactive in human, e.g. commercially 
available tablets of Spirulina contain 127 – 244 μg/ 100 g vitamin B12 analogues28. 
Moreover, widely consumed edible algae such as dried green (Enteromorpha sp.) 
contain (63.6 – 69.2 μg/ 100 g of dry weight) and purple lavers (Porphyra sp.) contain 
considerable amounts of vitamin B12 analogues (133 μg/ 100 g dry weight), however 
the biological activity of those algae derived corrinoids in human still remains 
unclear
29,30,31
. Fermented foods have been also tested, such as Tempeh (type of 
soybean) which contains 0.7 – 8.0 μg/  g ita i  B1232, “aue k aut .  μg/  g  
a d fe ug eek jui e fe e ted ith la ti  a id a te ia .  μg/  l 33. 
 
Some of the vitamins B12 analogues, apart from the fact being biological inactive, can 
also block the vitamin B12 metabolism in mammalian cells
34
. Due to the limited 
availability of natural sources of vitamin B12, and because in most cases the biological 
activity of the cobalamins is uncertain, further research in the field of plant-based 
sources is on demand. Finding new plant-based consumable products might help    
all kinds of vegetarians to have an extra alternative to consume vitamin B12.    
Besides, fortified products or vitamin B12 supplements contain artificial vitamin B12 
(cyanocobalamin), which has been generated by a derivatization of the highly toxic 
potassium cyanide. Additionally, artificially vitamin B12-enriched products may not be 
compatible with the philosophy of vegetarians.  




2. Aim and Scope 
Despite the general agreement that plants can not synthesize vitamin B12, there are 
reports that some plants contain detectable amounts of vitamin B12
35
. Robbins et al., 
(1950)
36
 suggested that vitamin B12 found in plants may in fact be of microbial (soil) 
origin. The medium-sized company Teutopharma GmbH, in the 90s launched a plant-
based product from Hippophae rhamnoides berries, claiming that is contained 
amounts vitamin B12 similar to that in pig liver, one of the richest sources of vitamin 
B12. Their hypothesis was that the symbiosis of Hippophae rhamnoides with              
the nodule of Frankia alni could cumulate vitamin B12 into the berries of the plant. 
Intensive research in collaboration with the TCI confirmed that Hippophae 
rhamnoides contains vitamin B12
22
. Through regular quality controls the company 
found that the quantity of vitamin B12 had decreased over the years. They assumed 
either that the exhaustive usage of soil or climate change were the cause for this 
decrease. 
 
The introduction of high-performance liquid chromatography (HPLC) has facilitated 
the analysis of vitamin B12 in several matrices such as meat products, infant powder, 
nutritional supplements, but the determination of vitamin B12 and its analogues in 
plants and berries is still a great challenge. Owing to very low concentrations of 
vitamin B12 in plants, the sensitivity of the analytical method and the sample 
preparation are essential steps. Thus, before this thesis began there was a clear need 
for carefully documented methods for analyzing vitamin B12 (CN-cobalamin) as well 
as for new data on their occurrence in plants and berries. 
 
The aim of the thesis was on the one hand to establish an analytical method for the 
investigation and determination of vitamin B12 in a variety of natural plant matrices, 
on the other hand to identify and separate the active forms of cobalamins from 
inactive analogues of vitamin B12. HPLC-UV alone is not sensitive enough to detect 
vitamin B12 in a natural matrix that contains several interfering compounds. Due to 
the need for accurate determination of vitamin B12, a combined purification and 
concentration step with an immunoaffinity column should be developed in this work. 
The optimized analytical protocol for plant matrices should be based on the 
established non-plant  methods
37,38,13,26
. Heudi et al. have shown that the method 
is a good alternative to the standard microbiological assay (MBA) for cobalamin 
determination in food products such as milk-based infant formula powder
38
. Other 
research groups like Marley et al. have applied the immunoaffinity method for the 
analysis of vitamin B12 enriched products
13
; or for determining the vitamin B12 
content of different meat products (Guggisberg et al.)
37
. Watanabe et al. have 
implemented immunoaffinity columns after a solid phase extraction and a 








This thesis consists of three parts: The first part of the thesis reviews the vitamin B12 
literature mainly focuses on vitamin B12, the different vitamin B12 forms and 
functions, their role and the edible sources that can be found. The second part is the 
experimental section, in which an HPLC-UV method for analyzing cobalamin in 
various food items was developed, coupled with an HPLC-MS/MS method for 
separating the different forms of vitamin B12 and identifying the real vitamin B12. In 
the third part the optimized assay was applied to defense the vitamin B12 
concentration in various plant sources. The last section consists of the conclusion 











3. Theoretical Background 
3.1. Vitamins 
Vitamins are a wide group of organic compounds that are needed only in minor 
quantities. However they are essential constituents of food required for the normal 
growth, self-maintenance, and functioning of human and animal bodies
39
. Humans 
are not able to synthesize most vitamins and they consequently have to be obtained 
exogenously
40
. Vitamins are usually divided into two general classes: the fat-soluble 
vitamins, such as A, D, E and K1, and the water-soluble vitamins, B1, B2, B6, 
nicotinamide, pantothenic acid, biotin, folic acid, B12 and C (Table 3.1)
41
. Usually, a 
balanced diet can adequately supply the vitamin requirement of the body. A 
deficiency can result in hypovitaminosis and, if more severe, in avitaminosis
42
. A 
consequence of insufficient supply of vitamins by food intake, is not the only reason 
for hypovitaminosis or avitaminosis, but can be caused also by disturbances in 
resorption, by stress and by disease. The extent of vitamin supply can be assessed by 
determining the vitamin content in blood plasma, or by measuring a biological 




Table 3.1: Chemical structures, basic biological activities and recommended daily 
doses of water- and fat-soluble vitamins
41
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Tab.  3.1 continued 















1,2 shift of hydrogen 
atoms 
2.4 mg per day  
Thioctic acid  
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group transfer 
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Cofactor in hydroxylation  
60 mg per day  
p-aminobenzoic 
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50 mg per day 
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3.2. Vitamin B12 
3.2.1. Structure and Chemistry of Vitamin B12 
Vitamin B12 (Fig. 3.1) belongs to a group of compound (corrinoids), which all contain 
a complex ring system with cobalt as a central atom
37
. The central cobalt atom is 
complexed to four pyrrole rings, a lower a-ligand donated by the DMBI (5,6-
dimethylbenzimidazole) and an upper b-ligand. The upper b-ligand of the cobalt, 
which projects above the plane of the molecule, is covalently bound to one of 




. This vitamin includes three naturally 
occurring forms: desoxyadenosyl group (adenosylcobalamin or coenzyme B12), CH3-
(methylcobalamin) and OH-(hydroxycobalamin) and one chemically transformed 
form CN-(cyanocobalamin), differing only in the upper ligand
45
.     
 




From those forms, methylcobalamin and adenosylcobalamin are biologically active. 
Other forms such as hydroxycobalamin (or aquacobalamin) and cyanocobalamin 
must be metabolized to either of the two active forms in order to be used in human 
cells. 
 
The predominant form of vitamin B12 in nature is 5'-desoxyadenosylcobalamin and 
has 5'-desoxyadenosyl as the L-group. In eukaryotes this form is located primarily in 
the mitochondria. It serves as the cofactor for the enzyme methylmalonyl CoA 





predominant form in human plasma and within the cytosol. It serves also as           
the cofactor for the enzyme methionine synthase. Adenosylcobalamin and 
methylcobalamin are rapidly converted to hydroxycobalamin (exists in minor 
amounts in nature) when the carbon-cobalt bond is disrupted by exposure to light. 
The cobalt atom in hydroxycobalamin is fully oxidized in the Co(III) state, whereas in 
the 5'-desoxyadenosylcobalamin and methylcobalamin forms the cobalt exists as 
reduced Co(I) or Co(II)
43
. Cyanocobalamin is the most stable form, is obtained by 
reacting natural cobalamins with cyanide and it is the major vitamin B12 used in 




Figure 3.2: Structural formula of vitamin B12 and partial structures of vitamin B12 
compounds. The partial structures of vitamin B12 compounds show only those 
parts of the molecule that differ from vitamin B12.  ’-desoxyadenosylcobalamin; 
2) methylcobalamin; 3) hydroxycobalamin;  4) sulfitocobalamin; 5) cyanocobalamin 
44
 
3.2.2. Analogues of Vitamin B12  
Many analogues of vitamin B12 exist in nature, and are known with the name 
corrinoids
47
. Corrinoids carrying a base other than 5,6-dimethylbenzimidazole 
(DMBI) as the lower ligand (cobalt-coordinated nucleotide) are also found in nature. 
However, DMBI is essential for the binding of the vitamin to the intrinsic factor for its 
absorption. As a consequence corrinoids with lower ligand other than DMBI are 
biologically inactive in humans but have vitamin activity in microorganisms (Figure 
3.3)
27
. The corrinoids can be grouped into two major types: (1) cobamides, which 
contain substitutions in the place of ribose, for example, adenoside; and (2) 
cobinamides, which lack a nucleotide
43
. It is unclear whether vitamin B12 analogues 
are inert or inhibit vitamin B12-dependent reactions. Organisms such as Euglena 
gracilis and Lactobacillus leichmannii can distinguish microbiologically the analogues 





or cobinamides. The sources of vitamin B12 analogues are still unknown, whether 
they come from diet, gut bacteria, or endogenous break-down of vitamin B12. 




Figure 3.3: Structural formula of vitamin B12 and partial structures of B12               
related compounds showing the portions that differ from vitamin B12: (1) vitamin 
B12 or cyanocobalamin; (2) pseudovitamin B12 or factor IV; (3) factor A                                
(2-methyladenylcobamide); (4) factor S (2-methylmer-captoadenylcobamide);           
(5) factor IIIm (5-methoxybenzimidazolylcobamide); (6) factor III (5-





3.2.3. Stability and Degradation of Vitamin B12  
The stability of vitamin B12 (cyanocobalamin) depends on different conditions. It is 
fairly stable in crystalline form and aqueous solution at room temperature when 
protected from light. On exposure to light, the cyano group is cleaved to produce 
OH-Cbl, which occurs as aquacobalamin in neutral or acidic solution
48,49
. Because 
these two forms are equally biologically active, this photolytic reaction does not 
result in a loss of vitamin B12 activity. Cyanocobalamin exhibits optimal stability at  
pH 4 – 6, even at high temperatures42. Hydrolysis under heating in acidic and alkaline 
conditions results in biologically inactive degraded products. In the presence of 
strong oxidizing or reducing agents, such as vitamin C or SO2, iron (II) ions and 







3.3. Vitamin B12 in Human Metabolism  
3.3.1. Digestion and Absorption 
In food, vitamin B12 is bound to proteins known as R-proteins or R-binders. In order 
vitamin B12 to be absorbed, the peptide bond that binds vitamin B12 to the protein 
carrier must be broken. The process of absorption and digestion is relatively 
complex, occurs in a few stages and requires sufficient synthesis of hydrochloric acid, 
proteases and an intrinsic factor (IF), a glycoprotein secreted by the parietal cells of 
the stomach
17
. The activity of pepsin, an enzyme secreted in the stomach, helps 
vitamin B12 to be released from the R-binders found in foods. Once released, vitamin 
B12 binds with R-binders (also known as haptocorrins) secreted with the saliva. Then, 
as it bounds to these R-binders, vitamin B12 is transported to the small intestine 
where pancreatic proteases digest the R-binders. After the digestion vitamin B12 is 




Figure 3.4: Absorption, cellular uptake and enzymatic processes involving 
cobalamins (Cbl) in mammals. The intracellular trafficking to the two mammalian 




For the absorption of vitamin B12 into the blood stream two separate mechanisms 
have been found:  
I. The first mechanism is a receptor-mediated endocytosis that takes place in 
the distal ileum. The IF-Cbl receptor can be expressed only in the distal ileum 
of the intestines. Once inside the enterocytes vitamin B12 is released from the 
IF and then binds to holo-transcobalamin II protein (TCII), a protein carrier 
synthesized in the microvascular endothelium of the ileal villi
17
.  
II. The second absorption mechanism of vitamin B12 is the mass-action 
pharmacologic mechanism
51
. When vitamin B12 exists in large amounts, such 





B12 is absorbed by diffusion across the epithelial ileum. IF and bypasses IF-Cbl 
receptors are not required in this process
17
.  
3.3.2. Metabolic Function 
Several vitamin B12 dependent enzymes can be found in bacteria and algae. 
However, in mammalian cells there are only two. The first one involves the          
transfer of a methyl group from methylcobalamin to methionine synthase, a reaction             
that converts homocysteine to methionine. In this reaction, vitamin B12                
activates folate, whereas methionine is required for DNA methylation. The other 
enzyme, methylmalonyl CoA mutase, uses adenosylcobalamin for converting             
L-methylmalonyl-coenzyme A (CoA) to succinyl-CoA. This conversion plays an 
important role in the extraction of energy from proteins and fats
17,52
.  
3.3.3. Deficiency  
Although vitamin B12 deficiency is uncommon and unlikely to develop in healthy 
human beings in developed countries, groups of people with poor diets such as: 
elderly, vegans or ovo-lacto vegetarians, can develop deficiencies of vitamin B12. The 
most common causes are related to inadequate IF production, atrophic gastritis, 
interference with the ileal uptake of vitamin B12 due to disease, resection or 





Table 3.2: Health Conditions / Symptoms Associated with Vitamin B12 Deficiency
17
 
Types Results Clinical Manifestations 




Large, immature red blood  
cells, lower than the normal  
amount of white blood cells,  
abnormally low number of  











Psychiatric  Irritability 
Mild memory impairment 
Depression 





Tab. 3.2 continued 
Health  
Conditions 
 Multiple sclerosis 
Parkinson disease 
Alzhei e ’s disease 
Dementia 
Cancer 
Occlusive vascular diseases 
Congenital heart defects 
Osteoporosis 
Failure to thrive 
Premenstrual syndrome 
Neural tube defects 
 
Symptoms of vitamin B12 deficiency can be grouped into several categories, including 
neurological, hematological, and psychiatric effects. Extended deficiency leads to 
nerve degeneration and irreversible neurological damage. Characteristic symptoms 
of the above categories of vitamin B12 deficiency are listed in Table 3.2. Very often 
symptoms of vitamin B12 deficiency are misdiagnosed, and that is because vitamin 
B12 deficiency mimic symptoms of other health conditions such as Alzhei e ’s 
disease, amyotrophic lateral sclerosis, diabetic peripheral neuropathy, spinal cord 
compression, alcoholic peripheral neuropathy, and congestive heart failure
53,54
. 
Classical symptoms of vitamin B12 deficiency include synthesis of large, immature, 
oblong-shaped erythrocytes (megaloblasts) and myelin deterioration in both central 
and peripheral nervous systems
54
.  
3.3.4. Recommendation  
According to the Institute of Medicine (National Academies, USA), the recommended 
daily allowance (RDA) for the vitamin B12 is 2.4 μg/ d17,55. The actual daily amount 
that is needed to maintain a sufficient serum level to promote erythropoiesis and 
other blood functions is considerably smaller, however this recommendation 
assumes a 50 % absorption rate of vitamin B12 from the amount ingested with 
foods
17
. Also they state that so far there is no sufficient scientific evidence to set an 
upper intake level for vitamin B12 consumption
56
.  
3.4. Main Types of Vegetarian Diets 
As it is stated f o  egeta ia s all a i al flesh ust e e luded . The e a e se e al 
types of vegetarianism, the most common are listed in Table 3.3. Fruitarianism 
allows only fruit, nuts, seeds and plant, which can be gathered without harming the 
plant. Raw veganism includes fresh fruit, nuts, seed and vegetables, excluding every 
cooking process. Su vegetarianism apart from animal products excludes also 





In addition, strict vegans and Su vegetarians avoid products that may use animal 
ingredients (not included in product label) or products which use animal products in 
their manufacturing (cheeses that use animal enzymes, gelatin (from animal skin, 








 meat fish egg dairy honey Allium family 
vegan
a
 x x x x x  
ovo-vegetarian x x  x   
lacto-vegetarian x x x    
ovo-lactovegetarian x x     
raw vegan
b
 x x x x x x 
Su vegetarian
c
 x x x x x x 
fruitarian
d
 x x x x x x 
a
Excludes all animal flesh and animal products, milk, honey, eggs. May also exclude any 
products tested on animals, also any clothing from animals. 
b
Includes only fresh and uncooked fruit, 
nuts, seeds, and vegetables, excludes vegetables in the Allium family. Vegetables can be cooked 
only up to a certain temperature. 
c
Includes only fruit, nuts, seeds, and other plant matter that can 
be gathered without harming the plant. 
d
Excludes all animal products as well as vegetables in the 
Allium family. 
3.5. Bioavailability of Vitamin B12 in Vegetarians and Elderly People  
From the perspective of nutrient intake, vegetarian diets are usually rich in 
carbohydrates, ω-6 polyunsaturated fatty acids, dietary fibers, carotenoids, folic 
acid, vitamin C, vitamin E, and magnesium (Mg). On the other hand, these diets are 
relatively low in proteins, saturated fatty acids, ω-3 polyunsaturated fatty acids 
(particularly eicosapentaenoic and docosahexaenoic acids), vitamin A (retinol), 




Table 3.4: Nutrient imbalance in vegetarian diets 
 
Rich Low 
Fiber Vitamin A 
Vitamin C Vitamin D3 
Vitamin E Vitamin B12 
Folate Iron 
Magnesium Cholesterol 
ω-6 Polyunsaturated fatty acids ω-3 Polyunsaturated fatty acids 
Carbohydrates Saturated fatty acids 
 
Vegetarians have due to an increased consumption of fruits, vegetables, whole-





lower serum cholesterol levels, and low blood pressure
59
. Compared with non-
vegetarians, vegetarians also have: reduced rates of mortality due to ischemic heart 
disease (lower blood cholesterol), have lower incidences of hypertension, stroke, 
type 2 diabetes, and certain cancers
59
. Pawlak et al.
24
 showed that vegetarians are 
able to develop vitamin B12 depletion or deficiency despite their demographic 
characteristics, place of residency, age, or type of vegetarian diets. The reason is that 
non-animal derived products are generally poorly absorbed. Characteristic examples 
are: the bioavailability of vitamin B12 from cooked eggs is 3.7 – 9.2  %, the vitamin B12 
content of various types of milk is very low (approximately 0.3 – .  μg /  g 60, and 
significant losses of vitamin B12 occur during the processing of milk
61
. These 
observations explain why vitamin B12 deficiency is relatively common in lacto-ovo-
vegetarians.  
 
A considerable proportion of elderly people with low serum B12 levels without 
pernicious anemia have been recently reported to have malabsorption of protein-
bound B12 (food-bound B12 malabsorption). Vitamin B12 malabsorption occurs with 
certain gastric dysfunctions, particularly atrophic gastritis with low stomach acid 
secretion
62
. However, vitamin B12 deficiency can be undetected in vegetarians 
because their diets are rich in folic acid, which may covers vitamin B12 deficiency until 
severe health problems occur
63
. Thus, strict vegetarians and elderly people are at 
higher risk for developing cobalamin deficiency, and in order to prevent that, 
consuming vitamin B12 fortified products or vitamin B12 containing supplements, can 
be a good measure of prevention.  
3.6. Vitamin B12 in Foods 
Vitamin B12 in foods can be found in several forms, including adenosylcobalamin, 
hydroxycobalamin, methylcobalamin, cyanocobalamin, and sulfitocobalamin
64,44
. 
Hydroxycobalamin and methylcobalamin are better absorbed than the other forms, 
however adenosylcobalamin and hydroxocobalamin are the predominant sources in 
foods
65
. Major contributors of vitamin B12 in the human diet are animal-based foods 
such as meat, fish, eggs and dairy products. Vitamin B12 is accumulated in animal 
tissues or milk, primarily due to gut microbial activities and feed supplements
45
. 
Apart from animal-based sources, vitamin B12 can be found in very small amounts 
exclusively in plant foods such as cereal, breads, pies, and even cookies, due to 
either contamination during processing, adding of small amounts of ingredients 
derived from products of animal origin (milk solids) or fortification. However, the 
amount of cobalamin in the majority of these foods, except foods fortified with 
vitamin B12, is negligible
17
.  
3.6.1. Animal-Derived Food Sources Containing Vitamin B12 
Meat organs such as liver and clams contain the highest amounts of vitamin B12. The 





more than 82 µg in 100 g of beef liver
17
. Most other meats contain between 1.2 – 3.5 
µg of vitamin B12 per 100 g. Bioavailability of vitamin B12 from meats ranges from 10 
% in liver to as much as 90 % in ground-cooked mutton patties
17
. The vitamin B12 
content of fish ranges from 3.0 – 8.9 µg/ 100 g. The dark muscle of skipjack is 
considered as one of the richest  sources of vitamin B12 (159 µg/ 100 g) of fishes
44
. 
Milk contains between 0.3 – 0.4 µg vitamin B12 per 100 g. The absorption rate of 
vitamin B12 from milk is around 65 %. Heat has a destructive effect on vitamin B12. 
The boiling process of milk can destroy 30 –  50 % of vitamin B12 depending on the 
duration of cooking, while pasteurization destroys 5 – 10 % of vitamin B12. The 
vitamin B12 content of dairy products such as cheese or cottage cheese recovers 
between 20 – 60 % in relation to that originally presented in milk. The whole egg 
contains between 0.9 – 1.4 µg /100 g vitamin B12. Most of the vitamin B12 in an egg is 
found in the yolk. The bioavailability of vitamin B12 from eggs depends on the 
preparation method (egg, scrambled egg, boiled egg) and ranges from about 4 % to a 
little more than 9 %
17,44
.  
3.6.2. Plant-Derived Food Sources Containing Vitamin B12 
In the United States many foods are fortified with vitamin B12 and comprise a high 
proportion of the dietary vitamin B12 intake
56
. This i ludes e eals su h as Kellogg’s 
Special K, Wheat Bran Flakes, Total, Total Raisin Bran, All Bran Original, soymilk, and 
soy meat analogues such as MorningstarFarms Burger Crumbles. These foods 
contain from less than the RDA to more than 200 % of the RDA of vitamin B12. 
Fortified breakfast cereal with folic acid, vitamins B12 and B6 has been recommended 
by several research groups as it increases the blood concentrations of these vitamins 
and decreases the total homocysteine concentrations in the plasma of elderly 
subjects
66
. Hence, vitamin B12-fortified breakfast cereals may be a particularly 
valuable source of  vitamin B12 for vegetarians
20
. However, vegetarians avoid 
strongly also processed foods in addition to animal products. Thus, the identification 
of plant-derived food sources that naturally contain a large amount of vitamin B12 
became necessary in order to prevent vitamin B12 deficiency in vegetarians
20
. 
3.6.2.1. Vitamin B12-Enriched Beans and Vegetables Using Organic Fertilizers or 
Hydroponics 
The addition of an organic fertilizer such as cow manure significantly increased the 
vitamin B12 content of spinach leaves, i.e., approximately .  μg/ 100 g fresh 
weight
20
. Nevertheless, the consumption of several hundred grams of fresh spinach 
would be insuffi ie t to eet the RDA of .  μg/ day for adult humans56,67.  
 
Researchers attempted to prepare vitamin B12-enriched vegetables by treating them 
with a solution that contains high levels of vitamin B12. Thus, the plant vitamin B12 





be particularly beneficial to vegetarians
68,69
. However, artificially vitamin B12-
enriched vegetables may not be compatible with the philosophy of vegetarians. 
3.6.2.2. Fermented Beans and Vegetables 
The content of vitamin B12 in soybeans is very low, with the exception of a fermented 
soybean-based food called tempeh that contains a considerable amount of vitamin 
B12 (0.7–8.0 μg/ 100 g)32. The increased vitamin B12 content of tempeh during its 
production may occur from bacterial contamination
70
. Other fermented soybean 
products such as Natto
71
, Korean soybean products (doenjang, chungkookjang, and 
kochujang) contain minute amounts of vitamin B12 (0.1 − .  μg/ 100 g)72. Also trace 
amounts of vitamin B12 were found in broccoli, asparagus, Japanese butterbur, mung 
bean sprouts, tassa jute, and water shield
73
. Fermented Korean vegetables such as 
kimuchi contain traces (<0.1 μg/ 100 g) of vitamin B1272,74. Various fermented tea 
leaves contain trace amounts of vitamin B12 (0.1 − .  μg/ 100 g dry weight)75,76. The 
juice of fenugreek (Trigonella foenum graecum) leaves can be enriched with vitamin 
B12 (12.5 μg/ 100 ml) by certain lactic fermentations77. The addition of 
Propionibacteria to cabbage during sauerkraut production results in higher 
concentrations of vitamin B12 .  μg/ 100 g)33.  
3.6.2.3. Edible Algae 
Several types of edible algae are consumed worldwide as food sources. However, the 
most widely consumed edible algae are dried green (Enteromorpha sp.) and purple 
lavers (Porphyra sp.) and contain substantial amounts of vitamin B12 (approximately 
 μg/ 100 g dry weight)29,30. Apart from these two, other species of edible algae 
contain no vitamin B12 or only trace amounts
78
. The algal corrinoid compounds of 
dried purple and green lavers were purified and confirmed as vitamin B12
79,80
. A 
significant a ou t .  μg/ 100 g dry weight) of vitamin B12 was found in dried 
Korean purple laver (Porphyrasp.). However, seasoned and toasted laver products 
contain lower amounts of vitamin B12 app o i atel  .  μg/ 100 g dry weight)30. 
The biological activity of lyophilized purple laver (Porphyra yezoensis) was 
investigated in vitamin B12-deficient rats, and the results indicated that vitamin B12 is 
bioavailable in rats
81
. A nutritional study of six vegan children who had consumed 
vegan diets including brown rice and dried purple laver (nori) for 4 – 10 years 
suggested that the consumption of nori may prevent vitamin B12 deficiency in 
vegans
82
. Also biologically active vitamin B12 in Chlorella tablets (eukaryotic 
microalgae Chlorella sp.) have been used in human food supplements
31
. Edible 
cyanobacteria such as Spirulina, Aphanizomenon, and Nostoc are described in the 
nutritional labels of dietary supplements that contain high levels of vitamin B12. 
However, the substantial amounts of vitamin B12, measured in these commercially 
available supplements, were determined using microbiological methods, which 
cannot separate vitamin B12 from vitamin B12 inactive analogues
83
. These 





inactive in humans. Therefore, edible cyanobacteria and their products should not 
be recommended as sources of vitamin B12 for vegetarians.  
3.6.2.4. Edible Mushrooms 
Many species of wild mushrooms are widely consumed due to dietary importance of 
their nutritional and medicinal characteristics
84,85
. In European countries six wild 
edible mushroom species are well known among vegetarians. Porcini mushrooms 
(Boletus sp.), parasol mushrooms (Macrolepiota procera), oyster mushrooms 
(Pleurotus ostreatus), and black morels (Morchella conica) contain zero or trace 
levels (0.01 − .  μg/ 100 g dry weight) of vitamin B12. On the other hand, black 
trumpet (Craterellus cornucopioides) and golden chanterelle (Cantharellus cibarius) 
mushrooms contain considerable levels of vitamin B12 (1.09 − .  μg/ 100 g dry 
weight)
26
. Using the combination of immunoaffinity columns and LC/ESI-MS/MS, 
purified corrinoid compounds from C. cornucopioides or C. cibarius were identified as 
vitamin B12. Consumption of approximately 100 g dried black trumpet 
(approximately 1 kg of fresh mushroom with 90 % moisture content), is 
recommended in order to reach the RDA le els fo  adults .  μg/ day), although 
ingestion of such large amounts would not be feasible
27
. Nevertheless, moderate 




3.7. Industrial Production of Vitamin B12 from Bacteria 
Over the last years, vitamin B12 has received much attention because of the 
increasing demand on the world market. Due to highly complicated and costly 
chemical synthesis of vitamin B12, the commercial vitamin B12 produced exclusively 
via biosynthetic fermentation processes. For microbial production of vitamin          
B12, there are two types of processes, the aerobic and the anaerobic            
fermentation
86
. Cultures of the anaerobic bacteria Propionibacterium shermanii or 
Propionibacterium freudenreichii etc. as well as cultures of the aerobic bacteria 
Pseudomonas denitrificans have been used successfully for the production of vitamin 
B12. The above bacteria have been used from industrial companies due to their rapid 
growth and high productivity
87
. The implementation of random mutagenesis is a 
common strategy for generating strains that produce high yields of vitamin B12
87
. It 
has also been reported that cobalt-resistant strains of propionibacteria have 
enhanced vitamin B12 production
88
. Different metabolic engineering strategies have 
been applied to increase vitamin B12 production in P. freudenreichii
89
. A recombinant 
P. freudenreichii strain harbouring a plasmid containing hemA, from Rhodobacter 










During the microbial production process of vitamin B12 the resulting photosensitive 
compound of methylcobalamin and adenosylcobalamin are derivatized by 
subsequent cyanidation in the stable form of cyanocobalamin, and further purified 
with sequential extraction methods using organic solvents
91
. Nowadays, in the 
developed world contemporary consumers as well as vegans or vegetarians, demand 
increasingly Bio products and products with the least possible industrial processing. 
As a consequence, the research as well as the market has turned to find sources of 
high vitamin B12 content from plant products. Hence, nutritional supplements (plant-
derived) with high amounts of vitamin B12 will be on demand for people that follow 
diets such as veganism or vegetarianism, which suffer from vitamin B12 absence. 
Developing markets such as Indian and Chinese promote many plant-based products 
labeled with vitamin B12 and  products enriched with vitamin B12. In most cases those 
claims are wrong, because they do not measure only the biologically active form of 
vitamin B12 but also inactive analogues of cobalamin. An important factor for the 
misleading labels is the analytical method used for the determination of vitamin B12, 
more specifically, the microbiological assay (MBA) does not differentiate between 
active forms of vitamin B12 and other corrinoids
45
. Before vegetarianism and 
veganism became way of life for the modern people of developed countries, a 
medium-sized pharmaceutical company in Lower Saxony (Germany) Teutopharma 
GmbH, came in the ea l  ’s ith a pio ee  idea that the symbiosis of nitrogen-
fixing actinomycete Frankia with actinorhizal plants may give the opportunity for a 
plant to be a potential producer of vitamin B12. As a matter of fact, based on this 
concept they discovered that the sea buckthorn (Hippophae rhamnoides), as a 
species of the family of actinorhizal plants, contains vitamin B12
92
. The company as 
pioneer in natural health-promoting products led the market and promoted sea 
buckthorn as a unique natural source of vitamin B12 from plants matrices, without 
the addition of artificial cyanocobalamin. Due to insufficiency of the developed 
analytical methods and high deviations of the measured concentrations, which led to 
uncertainty (concerning the real vitamin B12 content of the plant), the production 




Frankia is a genus of soil gram-positive actinomycetes, famous for its ability to form 
N2-fixing root nodule symbioses with actinorhizal plants. It is a filamentous free-
living bacterium found in root nodules or in soil
95
. The classification of the genus 
Frankia has been made in the order of Actinomycetales, on the basis of morphology, 
cell chemistry, and 16S rRNA sequences
96
. Frankia is the only species of 
Frankeniaceae with the capacity to fix nitrogen. This microaerophilic bacterium is 








Figure 3.5: The host specificity in actinorhizal symbioses is shown in a simplified 
scheme adapted from Benson and Clawson
98
; the numbering of Frankia clusters is 
adapted from Normand et al
94
. Legumes (Fabales) are indicated in black, Fagales in 
red, Rosales in blue and Cucurbitales in  green. Thick arrows connecting a Frankia 
cluster with a group of plants indicate that members of this cluster are commonly 
associated with the plants. Dashed arrows indicate that members of this cluster 
have been isolated from or detected in an effective or ineffective nodule of a 
member of the plant group at least once. It should be pointed out that not all 





The Frankia genus includes four phylogenetic clusters
94
. These clusters reflect 
Frankia–host range and Frankia–host–plant biogeography. Frankia strains in Cluster I 
are associated with Alnus, Myrica, Comptonia and Casuarina hosts. In Cluster II 
Frankia strains occur in nodules of Coriaria, Datisca, Purshia, Ceanothus, and Dryas. 
Colletia with the other actinorhizal Rhamnaceae of South America, Morella, 
Gymnostoma and the Elaeagnaceae are nodulated by cluster III Frankia strains (Fig 
3.5). An additional cluster IV group of strains forms a broad group of a typical Frankia 




Frankia as a generic name was proposed by Brunchorst (1886 – 1888) for the 
microorganism in nodules of Alnus and Elaeagnaceae
95
. Due to difficulties in 
isolating Frankia into pure cultures, knowledge about Frankia was previously 
restricted to its symbiotic stage. Pommer (1959)
101
 most likely made the first 
successful and well described isolation from Alnus glutinosa nodules, but his cultures 
were unfortunately lost
95
. After twenty years was reported from Callaham et al. 
(1978)
102
 isolation of Frankia CpI1 from Comptonia peregrina. After that, many 
isolates of Frankia occurred but not from all actinorhizal plant species. In case 
Frankia isolates are not available, crushed root nodules or soil must be used as 
inoculum. When Frankia is investigated in soil via a trap plant assay, the Frankia 












Depending on the culture conditions, in liquid culture Frankia forms hyphae and 
multilocular sporangia which are located on hyphae either terminal or intercalary
97
. 
Ultrastructure showed that sporangia are multilocular and contain the spores, the 
effective propagules of the bacteria, and the hyphae, free living structures are 
hollow. The site of nitrogenous activity are the vesicles, which are generally formed 
when nitrogen is very limited in the medium (Figure 3.6). Frankia inoculum is easier 
to conserve than Rhizobium inoculums due to the presence of resistant structure in 
culture
103
. However, the morphology of Frankia in the nodule varies according to 
host plant. The bacterial partner is responcible for the size of hyphae and the 




A perennial root organ called nodule, in which bacteria are hosted and nitrogen is 
fixed, is formed due to the symbiosis between actinorhizal plants and Frankia. In 
nature, actinorhizal nodule can have various forms and colors
105
. Two types of 




3.9. Actinorhizal Plants 
Plants nodulated by Frankia strains are known as actinorhizal plants; most are trees 
or woody shrubs. They are found in all continents apart from Antarctica. More than 
194 different plant species have been identified as hosts and are classified among 8 

















Subclass Family Genus Numbers of 
nodulated 
species 
Hamamelidae Betulaceae Alnus 47 










































Magnoliidae Coriariaceae Coriaria 5 
Dilleniidae Datiscaceae Datisca 2 
 
The actinorhizal plants have the tendency to grow in marginal soils and play an 
important role as pioneer species in early successional habitats. These plants inhabit 
in a variety of climates and ecosystems, including arctic tundra (Dryas), forests 
(Alnus, Comptonia, Casuarina, Criaria, and Sheperdia), coastal dunes (Casuarina, 
Hippophae, Myrica, and Elaeagnus), riparian habitats (Alnus, Myrica, and Datisca), 
and chapparal (Ceanothus, Comptonia, Cercocarpus, Cowania, and Purshia). Nitrogen 







 and some species can return up to 70 % of this nitrogen to 
the ecosystem
109
. Additionally to their importance as pioneering species, they play a 
significant role in land reclamation and stabilization, as sources of timber, biomass, 








3.10. Hippophae rhamnoides 
Hippophae rhamnoides (sea buckthorn) belongs in the family Elaeagnaceae, is a 
deciduous nitrogen-fixing spiny shrub or small tree between 2 – 4 m high. It is widely 
distributed on the Eurasian continent, on river banks and coastal dunes (such as 
Baltic coast of Finland or on the western coast and along the gulf of Bothnia in 
Sweden) and in Asia throughout the Himalaya regions including India, Nepal and 
Bhutan and in the northern parts of Pakistan and Afganistan
110
. The botanical genus 
name of sea buckthorn is Hippophae. The name Hippophae in greek, literally means 
shiny horse  e ause the a ie t G eeks used to feed it to thei  p ize a eho ses to 
keep them sleek and healthy
111
. This unique and valuable plant has recently gained 
worldwide attention, mainly for its medicinal and nutritional potential. Hippophae 
rhamnoides has yellow or orange berries (Fig 3.7), brown or black rough bark and a 
thick grayish-green crown. Leaves are alternate, narrow, and lanceolate with a silver-
grey color on the underside. This plant is ideal for soil erosion control, land 
reclamation, wildlife habitat enhancement, and farm shelterbelt protection, with 
nodule rooting capability of fixing nitrogen from the atmosphere
112
. It is a unisexual 
plant, in which male and female plants are different. Hippophae rhamoides needs 
about 4 – 5 years from the appearance of the first shoots from the seeds to the 
beginning of fruit and peaks at the 7-8
th 
year of plant life. With intermittent pruning 
it remains productive for 30 years. It flowers in April and the fruiting season is from 
August to October
113
. The plant can tolerate temperatures from – 43 to 40°C, grows 
in areas with mean annual temperatures ranging from 4.7 to 15.6°C and with annual 
precipitation ranging from 250 to 800 mm
114
. Like all Elaeagnaceae species 
Hippophae rhamoides has the capability of holding soil in fragile slopes, has no need 
for good arable land for its cultivation and has symbiotic relationships with nitrogen 
fixing actinomycetes known as Frankia in its root nodules
115
. The long networking 
roots of Hippophae rhamoides can also transform insoluble organic matters in the 
soil in its more soluble state. In many cases, five year old plants have a taproot of up 
to 3 m. However in forest areas with abudance of water can grow up to 15 m. Deep 
and horizontal roots extending between 6 and 10 m. The root turion starts to grow 
seedlings from the horizontal roots creating many new plants, after a period of 2 to 3 
years
110
. The symbiotic relationship between sea buckthorn and nitrogen fixing 
actinomycetes enables sea buckthorn to be planted in marginal soil
115
. In addition it 
is also a salt-tolerant plant as has been demonstrated in many places e.g., Central 
Asia, Siberia, Azerbaijan and China where populations of Hippophae grow well on the 










Figure 3.7: Sea buckthorn (Hippophae rhamnoides L.) in India early September, 




A large number of bioactive substances can be found in all parts of Hippophae 
rhamnoides such as vitamins (A, C, E, K, riboflavin, folic acid, B12
92
), carotenoids (α, β, 
δ-carotene lycopene), phytosterols (ergosterol, stigmasterol, lansterol, amyrins), 
organic acids (malic acid, oxalic acid), polyunsaturated fatty acids and some essential 
amino acids
117
. Sea buckthorn contains vitamin C 3 to 16 times higher than that of 
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Tab. 3.6 continued 
 





Zhang, W., et al. (1989) 
Tong et al. (1989) 





Zhang, W., et al. (1989) 





Zhang, W., et al. (1989) 





Zhang, W., et al. (1989) 
Tong et al. (1989) 





Zhang, W., et al. (1989) 
Zhao et al. (1989) 
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There are many elements and trace elements in Hippophae rhamnoides. As listed in 
Table 3.6 which is a synopsis of individual element levels contained either in plant 
berries or from the plant juice. Bounous and Zaninni (1988) found that fruit maturity 
affects N, Ca, K, Na, Mg, Cu, Fe, Zn, and Mn contents
119
. An average weight for each 
berry is 0.016 g, and contains 11.0 % (w/w) moisture and 14.2 % (w/w) oil. Because 
of its various rich nutrients the berries of sea buckthorn are usually used to make 
beverages, which are beneficial for many group of people such as sportsmen, 








4. Experimental Part 
The determination of vitamin B12 in food and dietary supplement products is 
routinely carried out by various analytical methods. However, for the analysis of 
vitamin B12 two aspects have to be considered, the quantity of vitamin B12 and 
activity of vitamin B12. The quantity of vitamin B12 is not necessarily proportional to 
the activity of vitamin B12; thus, the distinguishing between them is important. 
Number of ways are available to measure the quantity of vitamin B12, but only a few 
bioassays are available to assess vitamin B12 activity such as macrocytic anemia 





For the quantitative determination of vitamin B12 the offi ial  ethods a e the 
Microbiological assays (MBA), which are the oldest and the most commonly used. In 
Methods of Analysis for Nutrition Labeling, three official methods are identified 
(AOAC Method 960.46, 952.20, and 986.23) which are suitable for the determination 
of vitamin B12 in a wide range of food matrices and vitamin preparations. The 
Microbiological assays count on the proliferation of bacterial cultures with the help 
of vitamin B12 (bacterial growth rate depends on vitamin concentration in the test 
medium)
121,122
. However, these methods have several disadvantages such as the low 
precision. The growth takes several days and they are not capable of distinguishing 
between true cobalamins and cobalamin analogues.  
 
Several studies on the quantification of vitamin B12 in different matrices have been 
reported in the literature. Most of them include radioisotopic assays
123
 or methods 
based on chromatorgraphic techniques. Other methods include atomic absorption 
spectrometry (AAS)
124










 and a combination of fluorescence resonance energy 




Liquid chromatography (LC) serves as a very efficient technique for the 
determination of vitamin B12, with UV or other detectors, such as fluorescence and 
electrochemical detection, but are less sensitive than the microbiological method. 
Due to their poor sensitivity, these methods are suitable for fortified food analyses 
but not for natural matrix determinations. However, with clean up and pre-
concentration steps the ability to measure low concentrations of vitamin B12 can be 
significantly increased
11
. ICP-MS is one of the most sensitive detection methods for 
the analysis of trace level metal concentrations. Thus, the combination of LC-ICP-MS 
provides extremely selective detection, and matrix interference was minimized as 
the determination of vitamin B12 is accomplished through the measurement of the 
Co content
11










In the following chapters two analytical methods, an HPLC-UV and an HPLC-MS/MS, 
were developed for the determination of cobalamins and the active forms of vitamin 
B12 in natural matrices. HPLC-UV alone is not sensitive enough to detect vitamin B12  
in a natural matrix that contains several interfering compounds. Due to the need for 
accurate determination of vitamin B12, a combined purification and concentration 
step with an immunoaffinity column were applied. 
4.1. Analytical Determination of Vitamin B12 in Plants 
Sofar, Heudi et al. have shown that an HPLC-UV method combined with 
immunoaffinity column (concentration step) is a good alternative to the standard 
microbiological assay (MBA) for cobalamin determination in food products such as 
milk-based infant formula powder
38
. Other research groups like Marley et al. have 
applied this immunoaffinity method for the analysis of vitamin B12 enriched 
products
13
; or for determining the vitamin B12 content of different meat products 
and salami (Guggisberg et al.)
37
 Watanabe et al. have implemented immunoaffinity 
columns (IAC) after a solid phase extraction and a concentrating step in their 




Based on established non-plant analytical methods
37,38,13,26
 and an immunoaffinity 
column (IAC) protocol for the determination of cobalamin in plants, developed in a 
dissertation by O. Kysil. (Institut of Technical Chemistry at Leibniz University of 
Hanover)
22
, an analytical assay was optimized and specialized to isolate and analyse 
quantitatively the vitamin B12 content in plants. The analysis of vitamin B12 in plants 
is complex: the concentration of vitamin B12 is generally negligible or very low (in the 
range of 0 − 13 μg/ 100 g) and vitamin B12 exists in nature in several cobalamin forms 
with different degrees of stability. Therefore, the isolation, extraction, purification 
and analysis of vitamin B12 from a complex matrix such as plants and berries, with 
reproducible results and validation studies was not easy to reach. In terms of better 
understanding and for the sake of simplicity, the justification of the analytical 
method development, is divided into four main parts. Each part of the method will 
be studied separately in the following chapters. The Figure 4.1 below demonstrates 














                      
 
 
Figure 4.1: General flow chart for vitamin B12 determination  
 
4.2. Development and Optimization of Vitamin B12 Assay (stepwise 
process) 
4.2.1. Sample Homogenization 
Homogenization of samples is an early step in the process of isolation and 
quantification of analytes. Chemical, mechanical or physical methods are available 
for homogenization, but generally chemical methods are preferred for many sample 
types (e.g., E. coli and cultured cells). However, solid specimens, such as seeds, and 
heavily encased samples are not efficiently disrupted chemically. With such resilient 
samples mechanical and physical methods that rely on grinding, shearing, beating 
and shocking are used
129
. Mechanical homogenizers, manual homogenizers, mortar 
and pestles, sonicators, mixer mills, and vortexers are several of the more common 
tools used for mechanical and physical disruption. Homogenization, has a significant 
impact on the final results of a process. 
It is usually desirable to render solid samples into a fine powder state for the 
following reasons: 
i) A sample in a fine powder state is more homogeneous, allowing more 
representative sub-sampling with greater precision and accuracy if carefully 
mixed. 
ii) A fine powdered sample dissolves faster and is easier to extract because of its 
greater surface area. 
In our protocol, the choice of the appropriate homogenization method was crucial. 
In terms of differentiation, each sample that has been tested had different degrees 
of hardness. Thus, the developed method for reducing the particle size or grinding of 
solid samples had to be effective enough in a variety of samples such as plants, 
berries, juices, meat and tablets, etc. All the samples were treated as described in 
the sample preparation procedures (Appendices 6.1.2), as well as blank spikes of 
cobalamin. The effectiveness of each method was investigated by measuring the 
liberation of vitamin B12 from the analysed matrix applying the protocol of the 
Extraction of Vitamin B12 
Purification and Concentration of Vitamin B12 






method. For the homogenization of the samples and the liberation of the encased 
vitamin B12, four different methods were tested in different combinations. General 
characteristics of each grinding instrument are described below: 
 
i) Mortar & Pestle (Cryogenic Grinding)129: Mortar & Pestle are used for grinding 
samples frozen in liquid nitrogen. This cryogenic grinding makes the sample 
brittle and fracture easily, but it also preserves analytes that are heat labile or 
which may rapidly degrade upon liberation, such as RNA. With dry grinding, it is 
possible to generate very small particles. However, they are indispensable for 
grinding solids at room temperature.  
 
ii) Mixer Mill130: This grinding technique enhances the reproducibility and efficiency 
of grinding as well as the size reduction of the sample, which can reach levels 
of    5 µm. A mixer mill can mix and homogenize powders and suspensions in only 
a few seconds. It is also perfectly suitable for the disruption of biological cells as 
well as for DNA/RNA or analytes extraction.  
 
iii) Disperser131: Dispersing is a technique for mixing at least two substances that do 
not dissolve or hardly dissolve in each other and do not chemically react with one 
another. The goal while producing a dispe sio  is to eate a satisfa to il  fi e 
distribution in the continuous phase, and to disperse evenly the processed 
analyte so as the percentage of it to remain constant for any measured quantity.   
 
iv) Ultrasonic bath132: Ultrasonic homogenizing is a mechanical process to reduce 
small particles in a liquid so that they become evenly small and distributed. The 
objective is to reduce small particles in a liquid to improve uniformity and 
stability. These particles (disperse phase) can be either solids or liquids. 
 
The initial protocol of the method (Appendices 6.1.1) used as a grinding method a 
mortar & pestle with liquid nitrogen (cryogenic grinding). Due to insufficient 
homogenization of the sample Hippophae rhamnoides and to unreproducible 
analytical results, other methods were decided to be used, to see if they have better 
impact on the homogenization of the sample (optical inspection) and on the 
liberation of the encased vitamin B12 (analytically measured). An insufficient 
homogenization of the sample may have an impact on the recovery studies as well 
as on the precision of the method. Experiments were performed with samples of 
Hippophae rhamnoides with a defined amount (9 g) and the use of various 
combinations of different grinding methods (Fig 4.2). Apart from the initial grinding 
method (mortar & pestle), three new grinding methods were studied: mill 





combinations had as a basis the mill homogenizer instrument, and had been tested 
in all possible combinations.  
 
Figure 4.2: The influence of the grinding methods on the concentration (μg/ 100 g) 
of the extracted vitamin B12 from 9 g Hippophae rhamnoides berries and on the % 
RSD between replicate measurements. Grinding methods: A) mortar & pestle - 
cryogenic grinding B) mill homogenizer, C) mill homogenizer + disperser, D) mill 
homogenizer + ultrasonic bath, E) mill homogenizer + disperser + ultrasonic bath 
 
The use of the initial grinding protocol (mortar & pestle - cryogenic grinding) in 
Hippophae rhamnoides, yielded concentrations of vitamin B12 that ranged between 
0.05 – 0.10 μg/ 100 g dry weight, whereas the relative standard deviations between 
the replicate measurements was very high (  47 % RSD). After the application of 
different grinding methods the % RSD (Fig. 4.2) were reduced in grinding method B 
to 12.3 % RSD, in grinding method C to 7.7 % RSD, in grinding method D to 9.6 % RSD 
and the combination of all (method E) disclosed among a set of replicate 
measurements the lowest value of 1.7 % RSD. 
 
Moreover, the investigation of other grinding methods (see Fig. 4.2) indicated that 
each of them contributed positively to the increase of the determinable 
concentration of the vitamin B12, with the combination of all (method E) to extract 







































































grinding method (method A), the use of mill homogenizer increased the extracted 
vitamin B12 twenty one fold (1.68 μg/ 100 g), the combination of mill homogenizer 
and disperser resulted in forty one fold higher concentrations (3.29 μg/ 100 g), the 
combination of mill homogenizer with ultrasonic bath increased the concentration of 
vitamin B12 twenty six fold (2.11 μg/ 100 g). The combination of all grinding methods 
(method E) disclosed the highest determinable vitamin B12 value 4.12 μg/ 100 g.  
 
Based on the above results (Fig. 4.2), every grinding method revealed some 
weaknesses. The use of mortar & pestle alone, showed that is not capable to get an 
even grind and to reduce well enough the sample size. The use of mill homogenizer 
alone, decreased the % RSD among replicate measurements and contributed to the 
increase of the extracted vitamin B12, but the deviation among measurements was 
still high. The uniformity of the sample might be better than the use of mortar & 
pestle alone, but not good enough to reduce the size of the sample in order to 
extract all the encased vitamin B12. The combination of mill homogenizer with the 
disperser (griding method C) as well as the combination of mill homogenizer with the 
ultrasonic bath (grinding method D), improved significantly the % RSD among 
replicate measurements and the extracted amount of vitamin B12. However, only the 
combination of all available methods (grinding method E) achieved to overcome the 
weaknesses of individual methods and to increase the extracted vitamin B12 amount 
with a parallel decrease of the % RSD among replicate measurements. 
 
The application of different grinding methods in conjunction with the increase of 
vitamin B12 concentration in the analysed samples, disclosed that the real content of 
vitamin B12 in Hippophae rhamnoides had not been yet revealed. As a consequence 
of that, it came up the assumption that the real content of vitamin B12 might be 
higher than the expected one. Moreover, If we take under consideration that the 
immunoaffinty column has a capacity limit of 1.0 μg vitamin B12 per column, with 
optimal amount 0.5 μg/ per column, there was a significant possibility that the 
processed amount (9 g) contained higher amounts of cobalamins that overloaded 
the immunoaffinity column.    
 
Thus, a second step of the investigation was to check the influence of the sample 
amount parameter, in comparison with the previous experiment which was constant 
(9 g) (Fig. 4.2). Further experiments were performed. The sample amount was 
adjusted to the column capacity. The following combinations of grinding methods 
were applied: A) mill homogenizer, B) mill homogenizer + mortar and pestle, C) mill 
homogenizer + mortar and pestle + disperser, D) mill homogenizer + mortar and 
pestle + disperser + ultrasound bath, parallel with a reduction of the sample amount 
from 10 g to 0.5 g following the direction A to D (Fig. 4.3). Only with the use of mill 





RSD was 14. The combination of the mill homogenizer with a mortar & pestle and 
sample amount 7.0 g, decreased the % RSD to 11 and increased the extracted 
vitamin B12 (4.9 μg/ 100 g). The grinding method C (mill homogenizer + mortar and 
pestle + disperser) with 2.0 g sample amount showed a lower value of % RSD (4.63 % 
RSD) and higher amount of the extracted vitamin B12 (12.3 μg/ 100 g). The lowest 
sample amount (0.5 g) in combination with all the applied grinding methods (D) 
disclosed the highest extracted amount of vitamin B12 (37.0 μg/ 100 g) (Fig. 4.4), with 
the lowest relative standard deviation (0.7 % RSD) among replicate measurements 
(Fig. 4.3). 
 
In Figure 4.3 it becomes obvious that as the sample amount (g) reduces and extra 
grinding methods are added to the grinding process, the % RSD among replicate 
measurements decreases with parallel increase of the extracted vitamin B12 from the 
plant. The grinding method E of the first experiment (Fig. 4.2) and grinding method D 
of the second experiment (Fig. 4.3), differ only in the use of mortar and pestle, which 
was added extra in grinding method D. Apart from that, the basic parameter that 
differentiates these grinding methods is the sample amount. Even though the % RSD 
between the methods ranges in similar levels (1.7 – 0.7 % RSD), the vitamin B12 
extracted from 0.5 g sample yielded nine fold higher concentration (37.0 μg/ 100 g) 
than the extracted vitamin B12 from 9 g (4.1 μg/ 100 g). In this experiment, it was 
proved the assumption that the constant parameter of sample amount had a 
significant impact on the extraction of vitamin B12 from Hippophae rhamnoides. The 
initial choice of the sample amount (10 – 9 g) was proved unexpectedly large for 
processing, with content of vitamin B12 greater than the capacity limit of the 
immunoaffinity column. By extension, the large quantity of the sample could also 
create processing capacity problems with each of the grinding methods, and 







Figure 4.3: Influence of grinding method and sample amount (g) on the 
determinable concentration (μg/ 100 g) of vitamin B12 of Hippophae rhamnoides 
and on the % RSD among replicate measurements. Grinding methods: A) mill 
homogenizer, B) mill homogenizer + mortar and pestle, C) mill homogenizer + 
mortar and pestle + disperser, D) mill homogenizer + mortar and pestle + disperser 
+ ultrasonic bath 
 
Figure 4.4: % Extracted amount of vitamin B12 from Hippophae rhamnoides (558) 
after the application of different grinding methods in different sample amounts: A) 
mill homogenizer (10 g sample), B) mill homogenizer + mortar and pestle (7 g 
sample), C) mill homogenizer + mortar and pestle + disperser (2 g sample), D) mill 
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Two of the grinding methods (disperser and ultrasonic bath) were applied also in a 
liquid sample, to see the influence of the homogenization and the extraction ability 
in the liquid phase. Liquid extracts of black mustard were tested and followed the 
optimized protocol (Appendices 6.1.2) in order to measure the concentration of 
vitamin B12, parallel with testing the influence of the grinding method concerning the 
extraction ability. Replicate samples were divided in three groups. The first group 
passed the “a ple Ho oge izatio  step ithout using any of the existing grinding 
methods, the second group of replicate samples was processed with a disperser, and 
the third group of samples was processed with ultrasonic bath. The results as 
illustrated in Figure 4.5, prove that the application of the disperser and the ultrasonic 
bath, even in a liquid sample can extract higher amounts of vitamin B12, due to 
better homogenization and parallel reduction of the particle size of the liquid 
sample. In addition, a significant finding is that the % RSD (% relative standard 
deviation) between the replicate samples of the groups was di e e t. The  st g oup 
o g i di g ethod  had .    R“D, the se o d g oup dispe se  had    0.0 % RSD 
a d the thi d o e ult aso i  ath  .    R“D. Even though, the third group 
ult aso i  ath  pe fo ed ette  i  te s of the extraction of the vitamin B12 (1.65 
μg/ 100 ml) from the liquid matrix, the % RSD was much higher (8.5 % RSD) in 
comparison with the second group, which had approximately 0.0 % RSD. In 
conclusion, the application of the grinding methods (disperser and ultrasonic bath) 
supported the extraction of vitamin B12 content, and the disperser method 
contributed significantly to the improvement of % RSD among replicate 
measurements.   
 
Figure 4.5: Influence of grinding methods on the determinable concentration (μg/ 
100 ml) of vitamin B12 of black mustard (liquid extract) and on the % RSD among 




































































Summary – Discussion  
Several samples (solids and liquids) were tested, in order to specify the optimal 
parameters for an efficient grinding procedure, that can release the encased vitamin 
B12 quantitatively from the measured matrices and can determine the concentration 
of the vitamin B12 in the tested sample. The right method or the right combination of 
the methods had to comply with the following conditions: to grind the matrix into 
small particles, release the vitamin B12 content from the matrix, protect the 
measured analyte from heat, mix perfect the powder (homogenize) and dispersed 
evenly the vitamin B12 content so that the vitamin B12 percentage remains constant 
for any measured quantity. However, each of the tested methods proved that alone 
could not fulfill the above conditions. They showed high deviations among replicate 
measurements (mortar & pestle - 47.1 % RSD and mill homogenizer - 12.3 – 14.0 % 
RSD) and low extraction efficiency (   5.4 % - use of mill homogenizer (Fig. 4.4)). The 
sample amount was proved one of the most important parameters (Fig. 4.3), as 
initially overloaded the immunoaffinity column by exceeding the capacity limit. Thus, 
the adjustment of the sample amount to the capacity limit of IAC and the 
combination of all grinding methods contributed significantly to overcome all these 
weaknesses. Therefore, the sample amount of 0.5 g with the combination of all 
grinding methods (Fig. 4.3 - method D) achieved to improve the % RSD among 
replicate measurements and to extract efficiently all the encased amount of vitamin 
B12 from the plant. It also significantly improved the precision of the assay in solid 
samples such as Hippophae rhamnoides berries from 47.1 % to 0.7 % RSD and in 
liquid samples from 9.0 % to 0.0 % RSD.  
 
After the above experiments the “a ple Ho oge izatio  p o edu e su a ized 
as follows: Solid samples undergo an extended homogenization process. In the 
beginning, the sample is ground and homogenized to powder through a mixer mill (4 
g sample in each container). The mixer mill operates at 30 Hz for 2.5 min, and the 
jars are filled with 55 – 60 ml liquid nitrogen. Afterwards, the sample is perfected 
into a fine powder by the use of mortar & pestle. Then 0.5 g of fine powder, (the 
sample amount is depending on the vitamin B12 content of the sample) are diluted in 
10 ml buffer (in a 50 ml Falcon tube) and processed in a disperser with 24,000 rpm/ 
min, for 6 minutes. After the disperser, a fine homogenized suspension is prepared. 
The suspension (in the Falcon tube) sinks into an ultrasonic bath for 30 min. After the 
ult aso i  ath the suspe sio  is ead  fo  the E t a tio  of Vita i  B12  p o edu e. 
Liquid samples (10 – 30 ml) are stirred well to ensure the homogeneity of the 
sample, afterwards undergo the extended homogenization process from the 
disperser step until the ultrasonic bath. The “a ple Ho oge izatio  procedure is 








1) Mixer Mill 














































Figure 4.6: Flow chart of the optimized process “a ple Ho oge izatio . A  “olid 
samples follow the flow chart from step 1 to 4, B) Liquid samples follow the 







4.2.2. Extraction of Vitamin B12 
After the “a ple Ho oge izatio  step as described above, the extraction process 
was performed as it written in the initial protocol (Appendices 6.1.1). All forms of 
vitamin B12 were prior converted to the most stable form CN-cobalamin. This 
conversion was performed by heating the samples at 100 °C for at least 30 min in the 
presence of KCN. At this temperature (100 
o
C), enzymes/proteins such as pepsin and 
amylases, which have been added during the extraction process to improve vitamin 
B12 release from the plant matrix, are denatured prior to immunoaffinity step. The 
amylase treatment was also introduced to improve the filtration of the sample, by 
obtaining clear supernatants, particularly for plants containing starch. For high-fat-
containing samples the filtration was performed twice, so as to obtain a less viscous 
and easier to handle solution for further processing.  
 
For the release of vitamin B12 from the plant matrix, an incubation process of the 
enzymes (pepsin and α-amylase) at 37 oC, in which they have maximum activity, was 
necessary. However, the duration of the process had to be investigated. Thus, the 
effect of incubation time, of both enzymes, on the extraction efficiency was tested 
for 0.5 h, 1.5 h, 3.0 h, 6.0 h and 12.0 h. The results of the incubation times were 
examined statistically with Minitab 15 (statistical program) by one-way analysis of 
variance (ANOVA) (Appendices 6.2.1.). The highest concentration of vitamin B12 
released from the samples was detected at incubation times of 1.5 h and 3.0 h (after 
the 3.0 h until the 12.0 h the released vitamin B12 remained stable). These two 
incubation times were investigated further in detail by the Fishers Least Significant 
Difference (LSD) test. The difference between the two incubation times in regard to 
cobalamin release did not differ statistically significantly. Both tests (ANOVA and 
LSD) showed p values less than 0.05, indicating that the results are statistically 
significant. Thus, the short incubation time of 1.5 h was chosen for the enzyme 
digestion in further tests.  
 
Besides the optimum temperature, an important factor for the maximum activity of 
the enzymes was the pH. The optimum pH for pepsin ranges between pH 1.5 and pH 
1.6, and the optimum pH for α-amylase ranges between pH 6.7 and pH 7.0. Due to 
this difference, an optimal pH (for the highest extraction efficiency) had to be found, 
through the use of a buffer solution. The effect of the buffer pH on the extraction 
efficiency was tested carefully. The samples were diluted with acetate buffer at pH 4 
and after removal of all solid parts by filtration or centrifugation the pH of the 
supernatant was in the range of pH 3.3 – 4.6. In order to check the impact of the 
final pH on the analysis, samples were adjusted to different pH values in the range of 
pH 3 – 11. The samples were analyzed as described in the initial protocol 
(Appendices 6.1.1). The results are presented in Figure 4.7 and indicate that the best 





concentrations in the Hippophae rhamnoides samples were found. Thus, all further 
analyses were performed with a sample adjustment to pH 7 prior to the 
immunoaffinity step. 
 
Figure 4.7: The effect of pH adjustment, before the IAC, to the determinable 
vitamins B12 concentration in Hippophae rhamnoides extract (mean and 95% 
confidence intervals, n=3) 
 
As it is mentioned above, all forms of vitamin B12 were converted to the most     
stable CN-cobalamin prior to further analysis. According to the initial protocol       
(Appendices 6.1.1.) 1 ml of KCN (1% W/V) is added to the sample suspension.                       
However, an experiment was conducted in order to investigate the influence of      
the added KCN amount on the final concentration of vitamin B12, as well as             
the ability of the method to measure non-converted forms of cobalamins 
(methycobalamin (CH3-Cbl), hydroxycobalamin (OH-Cbl) and adenosylcobalamin 
(adeno-Cbl)). The experiment followed the initial method (Appendices 6.1.1.) with 


















































Figure 4.8: Effect of KCN (1% W/V) addition to the concentration of cobalamins in 
the analyzed sample (Hippophae rhamnoides). A) 0 ml KCN, B) 1 ml KCN, C) 3 ml 
KCN and D) 6 ml KCN 
 
From the Figure 4.8 it is obvious that the increased amount of KCN disclosed higher 
amounts of vitamin B12. This fact suggests that the recommended amount of 1 ml 
KCN 1 % (w/v) perhaps was not enough to convert all the existing cobalamins of the 
sample to CN-Cbl, and as a consequence the real amount of cobalamins might be 
higher. Another significant finding was also that without the addition of KCN, CN-
cobalamin was found. In this case, two assumptions can be made, either the special 
antibody that captures the CN-Cbl in immunoaffinity column (IAC) can also react with 
other cobalamins such as OH-Cbl, adeno-Cbl etc. or there is CN-Cbl present in the 
sample of Hippophae rhamoides which is very unlikely, because CN-Cbl is an artificial 
form of vitamin B12 and does not exist in nature.  
 
As it is already mentioned from other authors, for the conversion of cobalamins to 
CN-Cbl and the deactivation of the added enzymes/proteins, a heating step at 100 
o
C 
was necessary. An experiment was performed (initial protocol – see App. 6.1.1) to 
test the influence of the heating step to the liberation of the encased vitamin B12 
from the sample matrix. The test materials were berries from two different 
companies, Hippophae rhamnoides (sample code 558) from Teutopharma and 
Hippophae rhamnoides from Naturix24. The samples of each Hippophae rhamnoides 
(kindly provided by Teutopharma or Naturix24) were divided in two groups, one 
followed the normal protocol (with a heating step) and the other followed the 
protocol without the heating step. Based on the results (see Fig. 4.9) the heating 
step yielded 15 - 28 % higher concentrations of vitamin B12. That probably can be 







A)  0 ml KCN   
(1% W/V) 
B)  1 ml KCN   
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B12, from the analysed matrix, as well as due to the establishment of adequate 
conditions (100 
o
C) for the conversion of cobalamins to CN-Cobalamin.  
 
Figure 4.9: Effect of heating step (at 100 
o
C for 30 min) on the liberation of the 
encased vitamin B12 in Hippophae rhamnoides berries (bought from Teutopharm 
and Naturix24). A) Concentration of vitamin B12 including the heating step, B) 
Concentration of vitamin B12 without the heating step 
 
The next step of the protocol was the cooling process of the samples to room 
temperature. In the initial protocol (6.1.1.) the samples were left to cool down at 
room temperature for 2 hours, without any further process. Owing to the time-
consuming process of the assay, a cooling step with the use of an ice bath was 
decided to be used for 30 min. 
 
In many cases, it was observed that during the centrifugation procedure the 
precipitate could not be separated totally from the supernatant. Hence, a higher 
speed (5,000 rpm) at a lower temperature 3 
o
C was tested (optical observation) and 













































Hippophae rhamnoides (Teutopharma) 





Summary – Discussion  
The ai  of the Extraction of Vitamin B12  pa t as after the homogenization of the 
sample, the fine powder to be processed in a way, so as to extract and liberate the 
encased cobalamins from the matrix (with the most efficient way), and convert them 
to CN-cobalamin which is the target substance that can be determined from the 
method. The majority of the steps of this part were tested and optimized, in order to 
reach the optimal conditions for the extraction of the highest values of vitamin B12 
from the analysed matrix. Significant finding was the pH adjustment of the 
supernantant after the filtration step to pH 7, which yielded the highest 
concentrations of vitamin B12. The heating step at 100 
o
C was proved important for 
the conversion of all cobalamins to cyanocobalamin, as well as to the denaturation 
of added enzymes (which were used prior, to improve vitamin B12 release from the 
plant matrix), in order to be removed and not interfere further with the analyte.  
 
After all the above experiments the procedure of the ethod E t a tio  of Vita i  
B12  has ee  opti ized and summarized as follows: 1 ml of KCN (1% w/v), 1 g 
pepsin, a d  μl α-amylase are added to a fine homogenized suspension (10 ml of 
50 mM acetate buffer (pH 4.0) + 0.5 g fine powder), produced from the previous 
p o edu e “a ple Ho oge izatio . Then the suspension is incubated at 37 oC for 
1.5 h under agitation. The enzymatic reaction stops by incubating the sample in 
boiling water at 100 
o
C for 30 min. After cooling the sample in an ice bath for 30 min, 
the solution is centrifuged at 5,000 rpm for 25 min at 3 
o
C. The supernatant is 
collected and filtered through filter paper (589/2 Whatman, 90 mm). The pH is 
adjusted to pH 7 and the solution is quantitatively transferred to a volumetric flask 
and filled up to 100 ml with deionized H20.  The E t a tio  of Vita i  B12  





















Diluted solution with the extracted vitamin B12 
Water dilution (up to 100 ml) 
pH adjustment to 7 
Filtration of Supernatant 
Centrifugation (5,000 rpm, 3 oC, 25 min) 
Cooling (Ice Bath, 30 min) 
Heating (100 0C, 30 min)  
Incubation (37 0C, 1.5 h) 
Addition of Reagents  
(50 ml acetate buffer,  g pepsi ,  μl α-amylase and 1 ml of KCN       
(1% w/v))   
Fine Homogenized Suspension 





4.2.3. Purification and Concentration of Vitamin B12 
Afte  the opti izatio  of the “a ple Homogenization  a d E t a tio  of Vita i  
B12  se tio s of the initial p oto ol, the e t step Pu ifi atio  a d Co e t atio  of 
Vitamin B12  as follo ed as it as suggested  the a ufa tu e  of the 
immunoaffinity columns (IAC) and the authors from previous publication such as 
Guggisberg et al.
37
 with few adjustments. 
 
Based on the results of a publication, the solid phase extraction (SPE) C18 for vitamin 
B12 purification in food sample was proved insufficient (C. Pakin et al., 2005
133
). 
Similar results were found by Heudi et al.(2006)
38
, who found as well that the 
immunoaffinity column is clearly more specific for the determination of vitamin B12 
in various food products compared to conventional SPE cartridges such as C18. Thus, 
it was decided to use immunoaffinity columns (IAC) for the isolation of vitamin B12. 
The IAC were highly selective and reproducible for a variety of samples (meat, 
vitamin tables, etc.) and for more complex samples such as plant-based products 
(Hippophae rhamnoides, Inula helenium etc.). This high selectivity of an 
immunoaffinity column was necessary because of the pepsin treatment of the 
samples and because of the very low concentrations of vitamin B12 in plant-based 
products. Pepsin enzymatically hydrolyses the proteins into a variety of very small 
fragments, and boiling the sample at 100 °C leads to an immense number of UV 
active components that increase the risk of chromatographic interferences with 
vitamin B12.  
 
In order to check the reliability of IAC and see if they meet all manufacturer's 
specifications, the IAC was tested in recovery studies. According to the manufacturer 
of IAC a 5 – 15 ml aliquot (corresponding to 0.1 – 1.0  µg vitamin B12) of the sample 
extract has to pass through the column and then the column has to be washed by 10 
ml water. The bounded vitamin B12 (with the antibody of the immunoaffinity 
column) had to be eluted with methanol. Then, 3 ml of methanol (100 %) elutes up 
to 100 % of the vitamin B12. 
 
Based on this protocol, 1 ml of a standard solution of vitamin B12 with concentration 
0.1 μg/ ml, which meets the optimal column performance (0.01 – 0.5 μg vitamin B12 
onto the column), were passed through the IAC and the columns were subsequently 
washed with 10 ml water. At this point the IAC were eluted with 3 ml, 5 ml and 7 ml 
of methanol, respectively, so as to check the most efficient elution volume. The 
Figure 4.11 shows that 3 ml of methanol for the elution of the bound vitamin B12 are 
not enough to elute all the amount of the vitamin. In this case, the most efficient 
amount of methanol for elution of the vitamin B12 is 5 ml, which demonstrates 96 % 
recovery of the applied vitamin B12. Larger volumes of methanol could not improve 






Figure 4.11: Elution efficiency of vitamin B12 eluted with 3 ml, 5 ml or 7 ml 
methanol from immunoaffinity columns 
 
After the elution of the vitamin B12 from the immunoaffinity column, the methanolic 
extract followed an evaporation process to dryness, by drying the eluent at 60 
o
C 
under reduced pressure. An experiment was performed to check potential losses of 
vitamin B12 during the evaporation process. A series of standard solution of vitamin 
B12 were processed in the evaporation step to estimate potential losses of the 
vitamin during drying.  
 
Figure 4.12: Losses of vitamin B12 during the evaporation step, measured by a 
series of vitamin B12 standard solutions (0.05 - 0.75 μg/ ml) 
 
Based on the results (see Fig. 4.12) the losses of vitamin B12 passing through the 
evaporation step are very low and have no significant influence on the determinable 


































































Summary – Discussion  
The initial protocol (App. 6.1.1.) was studied in a stepwise process. Each step of the 
process was investigated, in order to be optimized and reach the optimum 
performance levels, for the best possible determination of the vitamin B12 in the 
measured samples. The final flow chart of the optimal assay was formulated as it is 























Figure 4.13: Optimized assay flow chart for the determination of vitamin B12 in 
various matrices 
Fine Homogenized Suspension 
Food Sample 
1) Mixer Mill  
2) Mortar & Pestle (Cryogenic Grinding)  
3) Disperser  





Extraction of Vitamin B12 
5) Addition of Reagents   
  6) Incubation (37 oC, 1.5 h) 
  7) Heating (100 
o
C, 30 min) 
8) Cooling (Ice Bath, 30 min) 
9) Centrifugation (5,000 rpm, 3 oC, 25 min) 
10) Filtration of Supernatant 
11) pH adjustment to pH 7 
12) Water dilution (up to 100 ml) 
Diluted Solution with the extracted vitamin B12 
Purification and Concentration of Vitamin B12 
13) Addition of sample (20 ml) to IAC 
14) Elution of vitamin B12 from IAC (5 ml methanol) 
15) Concentration of vitamin B12 in a Rotational 
Vacuum Concentrator (RVC) 
16) Reconstitution of vitamin B12 (0.5 ml 0.1% TFA) 
 





4.2.4. Analysis of Vitamin B12  
4.2.4.1. Detection of Vitamin B12 by HPLC-UV 
All the samples that have been analysed were processed through the optimized 
assay protocol (see Figure 4.13) with few differences, depending on the nature of 
the sample (liquid or solid). With the completion of the process, the extracted 
vitamin B12 was isolated, purified from other co-eluted substances (which they were 
present although the IAC has a specific antibody only for CN-Cbl), and concentrated 
in order to facilitate the quantification of its content. A reversed-phase high 
performance liquid chromatography (HPLC) method for the quantification of vitamin 
B12 from plant matrices has been developed (Appendices 6.1.1.4.) based on previous 
publication such as Heudi et al.
38
. The analysis of the samples were performed with a 
diode-array detector (DAD), the vitamin B12  was monitored at 361 nm, a C18 column 
   .  , .   μ  fitted ith a C18  pre-column filter (4 mm x 3 mm). The 
separation of the analyte carried out with a preparation of mobile phase consisted of 
0.025% (w/v) trifluoroacetic acid (TFA) in water solution and pure acetonitrile. The 
proportions of the eluents of the mobile phase have been optimized a few times, 
due to problems that appeared by co-eluted substances in the chromatograms or 
overlap of the anal te’s peak ita i  B12) from other substances. The elution of the 
vitamin B12 was perfomed with a gradient HPLC elution profile A as it is shown in 
Figure 4.14 below.  
 
 
Figure 4.14: HPLC gradient profile (A): Gradient elution of vitamin B12 with 0.025% 
(w/v) trifluoroacetic acid (TFA) in water (mobile phase A) and pure acetonitrile 
(mobile phase B) at a flow rate of 0.5 ml/min 
 
The development of the HPLC gradient profile was based on the sample of 
Hippophae rhamnoides, due to the complex nature of its matrix and the difficulty to 
separate the peak of vitamin B12 from the other co-eluted substances. After the 






































































































TFA (0,025 % W/V)  





rhamnoides, the method could not separate completely the vitamin B12 (extracted 
from Hippophae rhamnoides) from other co-eluted substances and the pattern of 
replicate samples was different. Also, it is clear from the Figure 4.15 that between 
7.0 min and 8.5 min the replicate chromatogram of the Hippophae rhamnoides had 
an impurity peak (Fig. 4.15 (C)). There are many causes for the presence of impurities 
in the column. The main reasons usually are either a dirty pre-column or column, or 
the elution of the left-overs (impurities) of the previous run during the next run. 
Consequently, odd peaks appear. 
 
Figure 4.15: A) Chromatogram of a standard solution of vitamin B12, B) + C) 
Chromatograms of the extracted vitamin B12 from Hippophae rhamnoides sample, 
after the application of the gradient HPLC elution profile (A)  
 
For all the above reasons, a stepwise cleaning and regeneration program of the 
column were performed as recommended by the manufacturer (Kinetex Columns). 
The C18 reversed phase column was cleaned by flushing with 10 – 20 column 
volumes of the following steps: 
1) 5:95 Acetonitrile / Water (or Methanol / Water) for buffer removal 
2) 95:5 Acetonitrile / Water (or Methanol / Water) 
3) THF (Tetrahydrofuran) 
4) 95:5 Acetonitrile / Water (or Methanol / Water) 
5) 5:95 Acetonitrile / Water (or Methanol / Water) 







The regeneration of the column was followed by a development of a new gradient 
HPLC elution profile (B) which included a washing step, so as to avoid remains of the 
previous sample to be eluted in the next run. The gradient elution of the new HPLC 
profile (B) is depicted in Figure 4.16. 
 
Figure 4.16: HPLC gradient profile (B): Gradient elution of vitamin B12 with 0.025% 
(w/v) trifluoroacetic acid (TFA) in water (mobile phase A) and pure acetonitrile 




Figure 4.17: A) Chromatogram of a standard solution of vitamin B12 and B) 
Chromatogram of the extracted vitamin B12 from Hippophae rhamnoides sample, 



















































































































TFA (0,025 % W/V)  






The HPLC gradient profile (B) was applied again in a Hippophae rhamnoides sample. 
The chromatograms disclosed improvements, concerning the appearance of 
impurities, which disappeared, as a result of an effective cleaning step of the 
modified method. Even though the chromatogram pattern of the standard solution 
of vitamin B12 and the vitamin B12 extracted from the sample (Hippophae 
rhamnoides) seemed similar, still the baseline separation of vitamin B12 was not 
complete, and the time of the run was longer (time consuming process). Thus, the 
HPLC profile was optimized for the third time and named HPLC gradient profile (C).  
 
Figure 4.18: HPLC gradient profile (C): Gradient elution of vitamin B12 with 0.025% 
(w/v) trifluoroacetic acid (TFA) in water (mobile phase A) and pure acetonitrile 
(mobile phase B) at a flow rate of 1.0 ml/min 
 
Figure 4.19: A) Chromatogram of a standard solution of vitamin B12 and B) 
Chromatogram of the extracted vitamin B12 from Hippophae rhamnoides sample, 













































































































TFA (0,025 % W/V)  






The purpose of the HPLC gradient profile (C) was to minimize the duration of the run, 
to keep vitamin B12 distinctly separated from other co-eluted substances, and at the 
end of the run to keep the column clear, with no remains from the previous runs. All 
the above parameters were achieved by the HPLC gradient profile (C) (Fig. 4.18) as it 
was applied to Hippophae rhamnoides sample (see Fig. 4.19). The HPLC gradient 
profile (C) (Appedices 6.1.2.4.) is the optimized gradient profile with the following 
characteristics. The total run time is 18.0 min, the vitamin B12 was detected with a 
retention time of tR= 4.15 min and after the completion of the run the column 
contains no remains. The HPLC gradient profile has been applied in all the samples, 
from plant matrices and vitamin B12 tablets until meat and liquid samples (juices) 
with great success, separating the extracted vitamin B12 from other co-eluted 
substances effectively. 
4.2.4.2. Detection of Active Vitamin B12 by HPLC-MS/MS 
After the collection of vitamin B12 fractions from Hippophae rhamnoides the sample 
with the concentrated vitamin B12 was dried and then reconstituted with 0.5 ml of 
0.1 % formic acid (water solution). An HPLC gradient profile for the differentiation of 
vitamin B12 analogues were developed by a mass spectrometry (MS) detector. For 
the identification of vitamin B12 and the determination of its molar mass, a high 
performance liquid chromatography coupled to a triple quadrupole mass analyzer 
was used. The MS was conducted in positive ion mode, electospray ionization (ESI) 
with a scan range of m/z 600 – 1,600 (see Appendices 6.1.2.5.). The vitamin B12  was 
monitored at 361 nm, on a C18 olu      ,  μ  at  oC temperature. 
The separation of the analyte conducted with a gradient elution 0.1 % (V/V) formic 
acid in water (mobile phase A) and 0.1 % (V/V) formic acid in acetonitrile (mobile 
phase B) at a flow rate of 0.3 ml/ min. The gradient conditions are described in the 
Figure below (Fig. 4.20). The total run of the method was 38.0 min and the vitamin 
B12 was detected with a retention time of tR= 15.1 min (Fig. 4.21). The chromatogram 
in Figure 4.21 of the 558 Hippophae rhamnoides sample contains inconsiderable 
peaks a d oise  at othe  ete tio  ti es e.g.  i , hi h a  i di ate the 
presence of other corrinoids in Hippophae rhamnoides sample. Due to low 
concentrations of vitamin B12 in the sample the analysis in MS was conducted in SIM 







Figure 4.20: HPLC-MS/MS Gradient profile: Gradient elution of vitamin B12 with   
0.1 % (V/V) formic acid in water (mobile phase A) and 0.1 % (V/V) formic acid in 




Figure 4.21: A) Chromatogram of cyanocobalamin (vitamin B12) standard solution 
concentration 0.25 μg/ ml, and B) Chromatogram of immunoaffinity purified 
















































































































0.1 % (V/V) formic acid in 
acetonitrile  






Summary – Discussion  
With the completion of the protocol of the method, a process for the qualification 
and quantification of vitamin B12 has been developed. For the detection of 
cyanocobalamin (vitamin B12) an HPLC gradient elution profile with UV detector has 
been applied successfully, as well as an HPLC elution profile with a mass 
spectrometry (MS) detector for the investigation of cobalamins structural forms. 
Both HPLC elution profiles contribute to the complete determination of vitamin B12  
in several matrices, with special interest in plant matrices. The developed HPLC 
profiles are depicted in Table 4.1.  
 
Table 4.1: Gradient elutions of HPLC-UV and HPLC-MS/MS profiles 
HPLC-UV * 










* HPLC-UV elution profile data: 
 Eluent A: 0.025% (w/v) trifluoroacetic acid (TFA) in water  
 Eluent B: pure acetonitrile  
 Column temperature: 30 °C 
 Flow rate: 1.0 ml/ min 
 Wavelength of the UV detector: 361 nm 
 Injection volume: 100 μl 
 
** HPLC-MS/MS elution profile data: 
 Eluent A: 0.1 % (w/v) formic acid (in water) 
 Eluent B: 0.1 % (w/v) formic acid (in acetonitrile) 
 Ion source: ESI (+) 
 SIM width: 0.700 amu total 
 The detector is set a fixed voltage: 1200.00 volt 
 Syringe pump flow rate: 1.00 μl/ min 
 ESI needle voltage positive: +5000.00 
 ESI needle voltage negative: +600.00 
 Drying gas temperature: 350.00 
 API housing temperature: 50.00 
 Nebulizer gas pressure: 55.00 
 Drying gas pressure: 30.00 
 Flow rate: 0.3 ml /min 
HPLC-MS/MS ** 










 Wavelength of the UV detector: 361 nm 
 Scan range of m/z: 600 – 1600 
 
4.3. Recovery Study 
In the present study, the recovery studies were focused on plant matrices, such as 
Hippophae rhamnoides, which was the guide material of the present method. The 
plants were first analysed (concerning the vitamin B12) by this assay, as there was no 
other available validated method to measure vitamin B12 in plant materials. The first 
measurements of different Hippophae rhamnoides samples confirmed the presence 
of vitamin B12. The determination of the recovery was based on the technique of 
standard solution addition to the analysed matrix, in which there is presence of the 
analyte (vitamin B12).  
 
Different food samples (liver, vitamin B12 tablets, and plants) were spiked with a 
defined amount of vitamin B12. All the samples were treated as described in the 
sample preparation procedures, as well as blank spikes (samples free of matrix 
spiked with known concentrations of vitamin B12). Samples such as liver, vitamin B12 
tablets, Inula helenium and blank spikes showed good recovery that ranged between 
80 – 100 %. However the recovery from Hippophae rhamnoides berries was very low 
(4.6 %). That was the reason for a thorough investigation of the reduced recovery in 
Hippophae rhamnoides, Generally, a low recovery can occur for two main reasons. 
The first reason is matrix effects (Takenaka et al. (1997)) and the second is 
insufficient homogenization.  
 
A series of experiments was performed based on the initial method (6.1.1), without 
performing the optimized homogenization method (see Fig. 4.6) with test sample 
Hippophae rhamnoides, in order to investigate the extensive losses of the spiked 
vitamin B12 amount. Spikes of vitamin B12 added in several steps of the process. The 
results showed that the deviation was very high between the replicate 
measurements and also among the values of the recovery in each step of the 
process. Thus, it was impossible to draw conclusions and specify the step of the 











4.3.1. Effect of Tested Material on Recovery 
A first corrective action was to spike with vitamin B12 a blank spike and observe the 
losses of vitamin B12 during the process without the presence of the matrix. The 
results yielded recovery more than 95 % of the spiked vitamin B12. The same 
experiment was repeated several times with spikes at different steps and confirmed 
that the blank spikes of vitamin B12 recovered up to 100 % in all steps of the process. 
First conclusion was that the reason of the losses was probably due to the matrix (in 
this case Hippophae rhamnoides (558)).  
 
Another plant sample (cranberries) was investigated in terms of recovery. The 
cranberries were spiked with known amount of vitamin B12 in three different steps: 
1
st
 spike, in the addition of the reagents. 2
nd
 spike, before the centrifugation process 
and 3
rd
 spike, during the sample addition at the immunoaffinity chromatography. 
Hence, the assay divided into 3 main parts. The 1
st
 spike of the vitamin B12 revealed 
recoveries between 60 – 70 %, the 2nd 70 – 80 % and the 3rd between 97 – 99 %. In 
this case, the results indicated that the losses of the spiked vitamin B12 was not only 
due to tested material, but probably resulted from steps contained in “a ple 
Ho oge izatio  a d/o  E t a tio  of Vita i  B12  procedures, as the third part of 
Pu ifi atio  a d Co centration of Vitamin B12  sho ed only minimal losses of 
vitamin B12. However, the deviation between the replicate measurements was still 
high. Further experiments were performed again with Hippophae rhamnoides (558) 
berries, but this time with spikes at 7 different steps of the process, in order to 
specify the losses of vitamin B12 in further detail. Based on the flow chart of the 
process in correlation with the results of the recovery studies (Table 4.2) it was 
disclosed that the recovery starts from 46 % (at first spike) and at the last spike (7) 
reached values of 106 % of the spiked vitamin B12. Similar results were obtained 
from another variety of Hippophae rhamnoides (Naturix24). It seems that the major 

















Table 4.2: Flow chart of the initial assay for the extraction of vitamin B12 from 




Process step Recovery 
Spike 1 Sample Homogenization 46 % 
   
 Addition of reagents  
   
 Incubation (37 
0
C, 3 h)  
Spike 2  43 % 
 Heating (100 
0
C, 35 min)  
   
 Cooling (room temperature)  
Spike 3  30 % 
 Centrifugation (4,000 rpm, 4
0
C for 25 min)  
Spike 4  70 % 
 Filtration  
Spike 5  80 % 
 pH adjustment to 7  
   
Spike 6 Water dilution (up to 100 ml) 99 % 
   
Spike 7 Sample addition (IAC) (20 ml) 106 % 
   
 Concentration of B12 (RVC) (5 ml methanol)  
   
 Reconstitution of B12 (0.5 ml 0.1% TFA solution)  
   
 HPLC-UV  
4.3.2. Effect of Heating Step on Recovery 
Based on the conclusions of the previous chapter (4.3.1.), it was decided to study the 
recovery of the added vitamin B12 with and without the heating step (100 
o
C for 30 
minutes), so as to check if heating was the reason for the extensive losses of vitamin 
B12. Samples from two different varieties of Hippophae rhamnoides berries (558 and 
Naturix24) were spiked at three different steps (3 replicate measurements) of the 
process, i ludi g the heati g step  a d ithout the heati g step : st spike at the 
addition of the reagents, 2
nd
 spike before the centrifugation process and 3
rd
 spike 






Figure 4.22: Effect of heating step on the recovery of the added vitamin B12 
 
The recovery data (Fig. 4.22) indicated that the absence of the heating step resulted 
in much lower recoveries in comparison with the presence of the heating step. Thus, 
it becomes obvious that the heating step had no negative influence on the recovery 
of the added vitamin B12, and is in accordance with the results of hapte  E t a tio  
of Vitamin B12  . . . , in which the absence of the heating step also resulted in 
lower values of the extracted vitamin B12. However, from the data of the normal 





 spike was approximately the same (47 – 50 %), which 
indicates that between those steps there were no further losses of the vitamin B12. 
With the technique of indirect proof, it became clear that the losses were ranged 
et ee  the ooli g step  a d ate  dilutio  step , this o lusio  suppo ted also 
from the Table 4.2 in which major losses of the spiked vitamin B12 disclosed in this 
area. After this experiment, it as de ided to he k the i flue e of the filt atio  
step  a d Ce t ifugatio  step .  
4.3.3. Effect of Filtration Step on Recovery 
In order to study the influence of the Filt atio  “tep  o e i g the losses of the 
spiked vitamin B12, 2 ml of standard solutions of vitamin B12 were prepared in three 
concentration levels (0.025, 0.050 and 0.100 μg/ ml), with the presence of 1 cm2 
filter paper (95 % cellulose) for 15 min and the same standard solutions without the 
presence of filter paper and they were measured directly by HPLC-UV. The time 
duration (15 min) was an estimation of the contact time between the sample and 






































% Recovery (558)  






Figure 4.23: Interaction of filter paper (95 % cellulose) with standard solutions of  
vitamin B12 in three concentration levels (0.025, 0.050 and 0.100 μg/ ml) 
 
Based on the results (Fig. 4.23) there are no significant differences between the 
values of concentrations of vitamin B12, whether the solution contains filter paper or 
not. Thus, in the following chapter the effe t of the  Ce t ifugatio  “tep  to ita i  
B12 will be studied.  
4.3.4. Effect of Centrifugation Step on Recovery 
The initial protocol (Appendices 6.1.1) was applied for the determination of vitamin 
B12 in Hippophae rhamnoides berries (Naturix24), with the only exception that the 
samples were treated in total with 50 ml buffer (50 mM acetate) (for concentration 
reasons), instead of 100 ml which was suggested in the protocol. After the 
e t ifugatio  step  the precipitate of the sa ple    9 g) was taken for sequential 
centrifugations, th ough the p o ess f o  i u atio  step  o l   addi g 50 ml 
buffer (50 mM acetate)) until the end of the process (HPLC-UV analysis). The 
purpose of the sequential centrifugations of the precipitate was to investigate the 
extraction efficiency and to estimate the real amount of vitamin B12 in the 
Hippophae rhamnoides sample (Naturix24). Based on the Nernst distribution law (1), 
the extraction coefficient of the process had to be stable in all sequential extractions. 
For the completion of the experiment the Hippophae rhamnoides sample (Naturix24) 
underwent seven sequential runs of the process (application of the overall protocol 






































Concentration levels of vitamin B12 standard solutions 





Nernst distribution law: KN = ΧcB / ΧcA     (1) 
where the ΧcB denotes the fraction of C in phase B and ΧcA denotes the fraction of C in phase A, at 
constant temperature, respectively. By convention, the concentration extracted into phase B 
appears in the numerator of the equation. The equilibrium constant is independent of the rate at 




Figure 4.24: Sequential extraction of vitamin B12 from Hippophae rhamnoides 
(Naturix24). Black line: Actual values from extracted amount of vitamin B12. Red 
dashed line: Extracted amount of vitamin B12 according the Nernst distribution law. 
Black bars: cumulative amount of vitamin B12 from the aggregate sequential 
extractions 
 
The results of the sequential extractions followed the normal way until the 5
th
 
extraction and then the values were higher than expected (red dashed line – Fig. 
4.24). Thus, the experiment stopped after the 7
th
 sequential extraction. 
Nevertheless, the findings of the experiment were significant. The extraction 
efficiency of the method was proved to be insufficient, if it is considered that the 
final concentration of vitamin B12 in Hippophae rhamnoides (Naturix24) was at least 
11.3 μg/ 100 g (Fig. 4.24), then the distribution coefficient of the process is 
approximately 0.332. However, the Figure 4.24 indicated that after the 7
th
 extraction 
the precipitate still contains amounts of vitamin B12, so the final concentration was 



















































































Number of sequential extractions 
Cumulative amount of vitamin B12 
Extracted amount of vitamin B12  





Based on these findings, the extraction procedure was insufficient and had to be 
optimized for better extraction efficiency. Probably, there was a correlation of the 
insufficient extraction of the analyte with the insufficient yield of the recovery 
studies. Moreover, another important reason of the insufficient recovery of the 
added vitamin B12, as it was mentioned above (4.3.), could be matrix effects 
(Takenaka et al. (1997)). In the next chapter matrix effects will be investigated.  
4.3.5. Effect of Matrix on Recovery 
The matrix effects were investigated based on the assumption that plants have high 
contents of minerals (especially in Hippophae rhamnoides
134
) and high contents of 




). Because of that, there 
is the possibility of complex formation among vitamin B12, vitamin C and specific 
minerals such as copper that may lead to destruction of vitamin B12. Under this 
hypothesis, possible interactions of vitamin B12 with the vitamin C, copper cations 
and their combinations were qualitatively investigated by UV/Vis spectroscopy.  
 
Based on our HPLC findings and literature
134,135
, a series of experiments took place in 
order to study all possible interactions, in conditions that could imitate (the best 
possible) the proportions of the above constituents (vitamin B12, vitamin C and 
copper cations) in Hippophae rhamnoides. In order to check the sensitivity of UV/Vis 
spectroscopy, the signal density of the absorption bands of the examined 
constituents was tested by preparing water solutions of vitamin B12 in concentrations 
between 0.2 – 20 μg/ 100 ml, and water solutions of vitamin C and Cu+2 in 
concentrations between 10 – 100 mg/ 100 ml. After a compromise between the 
signal density of the absorption bands and the proportions of the constituents in 
order to be similar with Hippophae rhamnoides, it was decided to prepare mixtures 
containing vitamin B12 (10 μg/ 100 ml), vitamin C (100 mg/ 100 ml) and Cu2+ (10 mg/ 
100 ml) in the following combinations:  
 V.B12,  
 V.B12 + V.C,  
 V.B12 + Cu2+ 
 V.B12 + V.C + Cu+2  







Figure 4.25: UV-Vis absorption spectra of water mixtures of vitamin B12 (10 μg/ 100 
ml) at pH 4 (R.T) of A) vitamin B12, B) vitamin B12 + vitamin C, C) vitamin B12 + Cu
+2
, 




The results from the UV-Vis spectra (Fig. 4.25) of different combinations of vitamin 
B12, revealed that the combination of vitamin B12 with vitamin C and Cu
+2
 (Fig. 4.25 –
D) introduced an effect on the  characteristic absorbance band of vitamin B12 at 361 
nm. As a first conclusion, the above combination of vitamin B12 + vitamin C + Cu
+2
 
indicated that either the vitamin B12 was destroyed or made a complex with the 
other constituents.  
 
Figure 4.26: UV-Vis absorption spectra of water mixtures of vitamin B12 (15 μg/ 100 
ml) at pH 4 (R.T) of A) vitamin B12, B) vitamin B12 + vitamin C, C) vitamin B12 + Cu
+2
, 








Figure 4.27: UV-Vis absorption spectra of water mixtures of vitamin B12 (20 μg/ 100 
ml) at pH 4 (R.T) of A) vitamin B12, B) vitamin B12 + vitamin C, C) vitamin B12 + Cu
+2
, 
D) vitamin B12 + vitamin C + Cu
+2 
 
Further investigations were conducted with higher concentrations of vitamin B12 
whereas the concentrations of the other constituents were kept constant (Fig. 4.26 
and Fig. 4.27), in order to find out whether there is an effect of vitamin B12 
concentration on the formation of the different combinations. In Figure 4.26 the 
mixtures contained 15 μg/ 100 ml vitamin B12 and in Figure 4.27 20 μg/ 100 ml 
vitamin B12, respectively. Both experiments (Fig. 4.26 and Fig 4.27) disclosed an 
overlap of vitamin B12 in relation with the combination of vitamin B12 + vitamin C + 
Cu
+2
, similar with the Figure 4.25. Additionally, the combination of vitamin B12 + 
vitamin C + Cu
+2
 presented a change of color (optical observation of the mixture) to a 
brass from the initial pale pink color. However, after soft stirring of the solution the 
color returned to initial pale pink.  
 
Figure 4.28 demonstrates data from Figure 4.26 measured again after 72 h at 
ambient temperature. The difference between Figure 4.28  and Figure 4.26 is shown 
in Figure 4.29. After 72 hours the absorption bands at 361 nm were increased in all 
combinations, especially in the combination of vitamin B12 + vitamin C and the 
combination of vitamin B12 +  vitamin C + Cu
+2
. In addition, a significant observation 
was that the stored solution of the combination vitamin B12 + vitamin C + Cu
+2
 after 
72 hours had a stable brass color, before and after intensive stirring. Probably the 






Figure 4.28: UV-Vis absorption spectra of water mixtures of vitamin B12 (15 μg/ 100 
ml) at pH 4 (R.T) measured after 72 hours. A) vitamin B12, B) vitamin B12 + vitamin 
C, C) vitamin B12 + Cu
+2






Figure 4.29: UV-Vis absorption spectra demonstrating the subtraction of Figure 











Figure 4.30: UV-Vis absorption spectra of water mixtures of vitamin B12 (15 μg/ 100 
ml) at pH 4 after heating at 100 
0
C for 30 min and measurement when the samples 
were warm. A) vitamin B12, B) vitamin B12 + vitamin C, C) vitamin B12 + Cu
+2
, D) 




Experiments were conducted to investigate the behavior of the same components 
(vitamin B12, vitamin C and Cu
+2
) during the heating step (100 
o
C for 30 min) of the 
assay. The same mixtures combinations containing 15 μg/ 100 ml vitamin B12 were 
divided in two groups, the first group was processed with a heating step at 100 
o
C for 
30 min and measured directly in UV/Vis (warm samples) (Fig. 4.30) and the second 
group underwent the same process, but measured after the samples were cooled 
down (R.T) (Fig. 4.31). Both spectra (Fig. 4.30 and Fig. 4.31) depicted a greater effect 
on the characteristic absorbance band of vitamin B12, in the combination of vitamin 
B12 + vitamin C + Cu
+2
, and a new overlap of vitamin B12 from vitamin C.  
 
To sum up, in ambient temperature conditions the previous spectra proved that only 
the combination of vitamin B12 + vitamin C + Cu
+2
 demonstrated an overlap of 
vitamin B12 absorbance band at 361 nm. However, with the addition of the heating 
step (100 
o
C for 30 min), a new overlap of vitamin B12 from vitamin C was revealed, 
in addition to the already known overlap among vitamin B12 + vitamin C + Cu
+2
. The 
results of UV/Vis spectra confirmed that matrix effects take place when vitamin B12 
co-exists with vitamin C and Cu
+2
, as a consequence the vitamin B12 disappears 







Figure 4.31: UV-Vis absorption spectra of water mixtures of vitamin B12 (15 μg/ 100 
ml) at pH 4 after heating at 100 
0
C for 30 min and measurement when the samples 
were cooled down. A) vitamin B12, B) vitamin B12 + vitamin C, C) vitamin B12 + Cu
+2
, 
D) vitamin B12 + vitamin C + Cu
+2 
 
After the above findings, and in order to confirm the results, similar experiments 
were performed quantitatively by the HPLC-UV method. Mixtures containing vitamin 
B12 (0.2 μg/ 100 ml), vitamin C (100 mg/ 100 ml) and Cu2+ (40 μg/ 100 ml) were 
prepared in different combinations. The mixtures were divided in two groups, the 
first group was processed under ambient temperature conditions and the second 
underwent a heating step at 100 
o
C for 30 min. Following the method protocol from 
the IAC step until the determination of vitamin B12 in HPLC, the results (Fig. 4.32) 
confirmed that the presence of vitamin C and Cu
2+
, separately and combined, in a 
vitamin B12 solution leads to severe destruction of vitamin B12. More specifically, the 
combination of vitamin B12, vitamin C and Cu
2+
 caused almost total loss of vitamin 
B12 (89 %). 
 
According to Takenaka et al.
137
 the destruction of vitamin B12 is assumed to be 
concerned with radicals generated by vitamin C in the presence of copper. In order 
to prevent that, he suggested the carnosine as a natural water-soluble antioxidant,  
for the protection of vitamin B12 in the presence of vitamin C and copper. From 
another point of view, EDTA was also suggested as chelating agent due to its high 
efficiency in extracting many metals
138
. In order to prove that, mixtures of vitamin 
B12, vitamin C and Cu
2+
 in concentrations similar to sea buckthorn berries were 
prepared (vitamin B12: 10 μg/ 100 ml, vitamin C: 100 mg/ 100 ml and Cu2+ 300 μg/ 





mM and 5 mM, respectively. The mixtures were measured at ambient conditions and 
after a heating step at 100 
o
C for 30 min. The results showed protection of vitamin 
B12 in the presence of vitamin C and Cu
2+
 with the addition of EDTA (0.5 mM and 5 
mM) and carnosine (5 mM) (Fig. 4.33).  
 
Thus, carnosine (5 mM), as the best additive protective, was used for the vitamin 
B12 assay or samples of Hippophae rhamnoides berries. Nevertheless, this addition 
did not cause any significant change (protection ability) in the analyzed 
concentrations, indicating that the immense loss of vitamin B12 in the assay was not 
only due to the vitamin C and  Cu
2+
 effect.  
 
Figure 4.32: The % destruction of the vitamin B12 in the presence of vitamin C and 
Cu
2+
, at ambient temperature and after a heating step (100 
o
C for 30 min) 
 
 
Figure 4.33: Protection of vitamin B12 by adding EDTA or carnosine, in a mixture 
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4.3.6. Effect of Homogenization Process on Recovery 
The homogenization process has already investigated in chapter 4.2.1 in relation 
with its impact on the extracted amount of vitamin B12 from the sample, as well as 
its impact on % RSD among replicate measurements (Fig. 4.3). However, the impact 
of the grinding methods in combination with the sample amount on the recovery 
studies has not yet been investigated. The following combinations of grinding 
methods were applied: A) mill homogenizer, B) mill homogenizer + mortar and 
pestle, C) mill homogenizer + mortar and pestle + disperser, D) mill homogenizer + 
mortar and pestle + disperser + ultrasound bath, parallel with the reduction of the 
sample amount from 10 g to 0.5 g following the direction A to D (Fig. 4.34). The 
outcomes of these combined experiments were that every new added grinding 
method contributed to gradually:  
i) increase of vitamin B12 concentration, whereas the combination of all grinding 
methods (method D) extracted the highest amounts of vitamin B12 (37.01 μg/ 100 
g), due to better homogenization and significant size reduction of the sample, 
that led to better liberation of the bound vitamin B12 (see Fig 4.3). 
ii) increase of the recovery values (following the direction A to D) of the spiking 
analyte (vitamin B12) up to 84 % (Fig 4.34). Similar levels of recovery were 
achieved with the other samples such as liver, vitamin B12 tablets, Inula helenium 
and blank spikes.  
iii) reduction of the matrix effects (complexation reactions of vitamin B12 with 
vitamin C and Cu
+2
), due to significantly lower quantity of the processed amount 
of the sample (0.5 g). 
iv) significant improvement of the precision of the assay from 14 to 0.7 % RSD, due 














Figure 4.34: Influence of grinding method and sample amount on the recovery of 
the spiked amount of vitamin B12 in Hippophae rhamnoides. Grinding methods: A) 
mill homogenizer, B) mill homogenizer + mortar and pestle, C) mill homogenizer + 
mortar and pestle + disperser, D) mill homogenizer + mortar and pestle + disperser 
+ ultrasonic bath 
 
Summary 
An extensive investigation carried out in order to determine the low recoveries, 
which appeared during the measurement of Hippophae rhamnoides. Several steps of 
the assay investigated in order to find out the source of vitamin B12 losses. After the 
previous investigations, we came to the conclusion that the main reasons for the 
extensive losses of vitamin B12 were the insufficient homogenization process, the 
sample amount and the matrix effects caused by the presence of vitamin C and 
copper cations. The optimized homogenization procedure overcame all these 
problems, and as a result the recovery of vitamin B12 in Hippophae rhamnoides 
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4.4. Stability of Vitamin B12  
Previous publications have highlighted the instability of vitamin B12 during ambient 
light conditions and thermal treatment processes, respectively
11
. Major attention 
was given to the stability of the analyte during sample preparation and analysis. The 
stability of vitamin B12 was tested with a series of standard solutions in the range of 
the method concentrations. The standards solutions of the analyte (vitamin B12) 
should be tested over at least a 48 hour period (depends on intended use), and the 
quantitation of components should be determined by comparison to freshly 
prepared standards
139
. For assay methods a stability criterion is that the sample, the 
standard solutions and the mobile phase will be stable for 48 h under defined 
storage conditions. The stability is considered to be acceptable when the change in 
the standard or sample response is within 2% relative to freshly prepared standards. 
 
Hence, fresh standard solutions were measured directly after preparation; the same 
standard solutions stored in a capped volumetric flask on a laboratory bench under 
normal daylight conditions at RT and were measured after 24 h and 48 h. Extensive 
losses were disclosed in concentrations at LOQ levels (10.80 % after 24 h and 21.33 
% after 48 h). In the area of the target concentration of the method (C=0.1 μg/ ml) 
the standard solutions showed relatively good stability, with losses of vitamin B12 
within 2.9 – 4.4 % for the first 48 hours. Although, the resulting values were not that 
close to the limit of 2 %, concentrations higher than 0.5 μg/ml remained stable for 
more than 2 – 3 days. Generally, as the concentration increased, the vitamin losses 
decreased in an inversely proportional manner (see Fig 4.35).  
 
Figure 4.35: Effect of ambient conditions (light and temperature) on the stability of 






Apart from the short-term stability of vitamin B12 in ambient conditions, significant 
interest had the stability of vitamin B12 in long-term duration for the determination 
of the ideal concentration of a stock solution. An experiment was carried out in 
order to investigate the effect of ambient light and temperature conditions on the 
stability of vitamin B12 after 4 days and 7 days (Fig. 4.36). 
 
 
Figure 4.36: Effect of ambient conditions (light and temperature) on the stability of 
vitamin B12 standard solutions (C= 0.025 – 1.000 μg/ ml) in a time period of 4 and 7 
days 
 
The graph in Figure 4.36 demonstrated that the concentrations of vitamin B12 
standard solutions decreased in an inversely proportional manner, both after 4 and 7 
days, respectively. The losses in each concentration level are higher after storing 
vitamin B12 for 7 days in ambient conditions compared to 4 days. Major losses 
occurred in a range of concentrations (0.025 – 0.600 μg/ ml) and the losses are 
gradually reduced as the concentrations reach higher levels from 0.7 till 1.0 μg/ ml. 
Concentrations higher than 1.0 μg/ ml are expected to be stable more than a week in 
ambient conditions. By combining the above results (Fig 4.36) with several relative 
publications, a stock solution of cyanocobalamin (vitamin B12) with higher 
concentration, such as 10 μg/ ml, under light protection at lower temperatures (4 
o
C),  can be stable for 2 months.  
 
One more experiment was conducted concerning the ambient light and temperature 





vitamin B12. Fresh standard solutions of vitamin B12 were prepared in replicates in 
the o e t atio  of .  μg/ l a d di ided i  t o g oups, o e e posed to a ie t 
light, and the second one kept in the dark. Both groups left in those conditions for 60 
h and then were measured by HPLC-UV. The results showed average 4.7 % losses of 
vitamin B12 of the first group (light-protected) and for the second group (light-
exposed) an average of 12.0 % losses of vitamin B12 (Fig. 4.37). Remarkable was that 
the concentration of vitamin B12 in the level of 0.5 μg/ ml, demonstrated 12 % losses 
in 2 ½ days, in contrast with the previous experiment (Fig. 4.36) in which the same 
concentration of vitamin B12 (0.5 μg/ ml) showed losses 10 % in 4 days. In spite of 
that, the results indicate that the long-term stay of vitamin B12 in unprotected light 
ambient conditions has a considerable impact to the stability of vitamin B12. It is 
strongly suggested that samples with vitamin B12 have to be handled under subdued 
light, as well as to use amber glassware or covered tubes.   
                      
Figure 4.37: Effect of ambient light to stability of vitamin B12 (C=0.5 μg/ml) after 60 
h exposure to ambient conditions 
 
The stability of vitamin B12 in a thermal treatment at 100 
o
C was investigated, as 100
 
o
C represents the highest temperature in which the analyte will undergo through the 
method protocol. The results showed that after 15 min duration the vitamin B12 
content was constant without losses, but after 30 - 45 min the losses increased to 
8.33 % of the initial vitamin B12 content (tested with 0.1 μg/ ml vitamin B12 standard 
solution). Therefore, samples during the thermal treatment stayed no longer than 30 
min at 100 
o
C, in order to avoid losses of the vitamin B12, and standard solutions of 
vitamin B12, which were used for studies (calibration plot, recovery, validation etc.), 
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4.5. Determination of Moisture Content  
Due to different moisture content of each one of the samples, before the application 
of the assay moisture content determinations were performed, in order to 
incorporate suitable weight corrections. The water molecules in a plant or meat 
product may be present in a variety of different molecular environments. Depending 
on their interaction with the surrounding molecules the water molecules in these 
different environments normally have different physicochemical properties.  
 Bulk water: - Bulk water is free from any other constituent so that each water 
molecule is surrounded only by other water molecules. 
 Capillary or trapped water: - Capillary water is held in narrow channels  by 
capillary forces. Trapped water is held within spaces in a food which are 
surrounded by a physical barrier that prevents the water molecules from 
easily escaping e.g, an emulsion droplet or a biological cell. 
 Physically bound water: - A significant fraction of the water molecules in 
many foods is not completely surrounded by other water molecules, but is in 
molecular contact with other food constituent e.g. protein, carbohydrate or 
minerals. 
 Chemically bound water: - some of the water molecules present in a food 
may be chemically bound to other molecules as water of crystallization is as 
hydrate e.g NaS04.10H20. 
 
Prior to moisture content analysis, it was important to prevent any loss or gain of 
water, as well as the selection of a representative sample. For this reason, the 
samples in order to avoid exposure to the atmosphere and to the fluctuation of the 
temperature, were stored in dark light-protected sealed containers. The moisture 
content of all samples was determined gravimetrically based on an oven-drying 
method (Appendice 6.1.3.). The samples were chopped into small size parts so as to 
extend the surface area of material exposed to the environment, and to remove the 
moisture with faster rate. Weighed samples were placed in an oven for 24 h at 90 
o
C 
until they reached a constant weight. The calculation of the moisture content could 
be expressed on a fresh weight (FW) basis or on a dry weight (DW) basis. 
 
% moisture(FW basis) = FW-DW  x 100 
                                        FW 
% moisture(DW basis) = FW-DW  x 100 
                                        DW 
However, the fresh weight (FW) basis is preferred, because it tends to minimize 
changes in water content, whereas the dry weight (DW) can change seasonally giving 
unsatisfactory results.  The results of the examined samples are listed in Appendices 






4.6. Validation Study for Vitamin B12 Assay 
The validation of analytical methods is an important regulatory requirement in 
pharmaceutical analysis. A valid analytical method has to provide documented 
evidence, and a high degree of assurance, so as  the employed analytical method for     
a specific test, will be suitable for its intended purpose
139
. Regulatory authorities, 
over recent years, have become increasingly aware of the necessity of ensuring              
that the data submitted to them in applications for marketing authorizations       
have been acquired using validated analytical methodology. The International             
Conference on Harmonization (ICH) has introduced guidelines for analytical methods 
validation
140,141
. The U.S. Food and Drug Administration (FDA) methods validation 
draft guidance document
142,143,144
, as well as United States Pharmacopoeia (USP)
145
 
both refer to ICH guidelines. These draft guidances define regulatory and alternative 
analytical procedures and stability-indicating assays. The FDA has proposed to add a 
section from the Code of Federal Regulations (CFR) 211.222, of analytical methods 
validation, to the current Good Manufacturing Practice (cGMP) regulations
146
. This 
would obligate pharmaceutical manufacturers to establish and document the 
accuracy, sensitivity, specificity, reproducibility, and any other necessary attribute 
(e.g., system suitability, stability of solutions) for the validation of methods. The first 
step in method validation is the preparation of a protocol. 
 
The overall assay for the quantification of vitamin B12 in plants was carefully 
validated, prior to a final LC-MS/MS assay of the vitamin B12 from Hippophae 
rhamnoides. 
4.6.1. Linearity and Range 
4.6.1.1. Linearity  
Accoording the International Conference on Harmonization (ICH) linearity of an 
analytical procedure is the ability (within a given range) to obtain test results that are 
directly proportional to the concentration (amount) of analyte in the sample
140
. The 
linearity has to specify a minimum of five concentration levels, along with certain 
minimum specified ranges. The minimum specified range is from 80 – 120 % of the 
target concentration. Acceptability of linearity data is often judged by examining the 
correlation coefficient and y-intercept of the linear regression line for the response 
versus concentration plot. Generally the regression coefficient (r
2
) > 0.998 is 
considered as evidence of acceptable fit of the data to the regression line. The y-
intercept should be less than a few percent of the response obtained for the analyte 
at the target level. The Percent Relative Standard Deviation (RSD), intercept, and 









In the present assay development, the target concentration is 0.1 μg/ ml vitamin B12. 
The 80 – 120 % range in our method includes concentrations from 0.08 – 0.12 μg/ ml 
vitamin B12. However, linearity was first investigated in a broaden range of vitamin 
B12 concentrations from 0.01 – .  μg/ l (10 – 700 % of nominal concentration, 
n=6) in order to specify the linear range of the method with statistical approaches. 
Fresh prepared standard solutions of vitamin B12 in ten levels (n=6) (0.01, 0.025, 
0.05, 0.10, . , . , . , . , .  a d .  μg/ l  e e a al sed di e tly by 
HPLC-UV. Usually, this relationship can be represented by the equation y = a + bx, 
where a is the y-intercept and b is the slope. The slope indicates the steepness of a 
line and the intercept indicates the location where it intersects an axis. The following 
regression equation was found by plotting the peak area (y) versus the vitamin B12 
concentration (x) expressed in μg/ ml:  
peak area = 69 + 333,814  vitamin  B12  μg/  ml) with R2 (adj) = 99.41 %.  
Whereas the intercept of the equation is 69 and the slope is 333,814. The value of 
the y-intercept (69) indicates the average peak area when the concentration of 
vitamin B12 is 0 μg/ ml. The value of the slope (333,814) indicates that for each 




Figure 4.38: Graphical presentation of the linear regression line (0.01 – 0.70 μg/ ml) 
with the 95 % confidence interval and prediction interval 
 
The demonstration of the coefficient R
2
 obtained from the regression line 
demonstrates a satisfactory relationship between peak area and concentration of 
vitamin B12 (Fig. 4.38). The data obtained from linearity experiments are presented 





Table 4.3: Assessment results of the linearity (range from 0.01 – 0.70 μg / ml 
vitamin B12) of the HPLC method, for the assay of vitamin B12 employing the 






0,1 µg/ ml 
peak area as mean of 
6 injections 
Peak area  
RSD (%) 
0.010 10 3435 7.37 
0.025 25 8077 7.36 
0.050 50 15619 1.63 
0.100 100 33126 0.34 
0.200 200 66212 0.80 
0.300 300 97068 0.53 
0.400 400 136549 10.64 
0.500 500 170088 0.32 
0.600 600 212407 1.22 
0.700 700 221165 9.33 
 
Before further examination of the regression, it was necessary to obtain a diagnosis 
of the validity of the regression through the graph of Figure 4.39.  
 
Figure 4.39: Graphs for the estimation of the normality of residuals (produced by 
statistical program MINITAB 17) 
 
Although, the results presented in the Table 4.4 demonstrated P value for the 
analysis of variance lower than 0.05, meaning that there is statistical significant 
linear regression (Fig. 4.38) between the measured peak area and the               
concentration levels of vitamin B12, the Figure 4.39 shows that the graphs of the 





approximately normally distributed) and the histogram of the residuals (shows      
the distribution of the residuals for all observations) are following the normal 
distribution but not in excellent way. It is observed that the graph of residuals versus 
the fitted values (estimated responses), are not dispersed uniformly. So the 
regression is not independent of the actions of x values and the fitted values. 
Additionally, by examining the results of Table 4.4 (*the abbreviations of Table 4.4 
are explained below), there are 2 observations (9 and 10) with a relative high value 
of standard residual. Thus, these two observations have to be examined further in 
order to ascertain whether their absence improve the adjustment of the regression 
line or not.  
 
Table 4.4: Regression Analysis: Peak area versus vitamin B12 C (μg/ml)  
 
Analysis of Variance 





Regression 1 63616656749 63616656749 1526,02 0,000 
vitamin B12 μg/ l  1 63616656749 63616656749 1526,02 0,000 
Error 8 333503777 41687972   
Total 9 63950160526    
Model Summary 
S 6456,62     
R-sq 99,48 %     
R-sq(adj) 99,41 %     
R-sq(pred) 98,83 %     
Coefficients 
Term Coefficient Standard error 
coefficient 
T-Value P-Value VIF 
Constant 69 3201 0,02 0,983  
vitamin B12 μg/ l  333814 8545 39,06 0,000 1,00 
Fits and Diagnostics for All Observations 
Observations Peak area      Fit    Residuals Standardized residuals 
1 3435 3407   28  0,00 
2 8077 8415 -338 -0,06 
3 15619 16760 -1141 -0,20 
4 33126 33451 -325 -0,05 
5 66212 66832 -620 -0,10 
6 97068 100213 -3145 -0,51 
7 136549 133595  2954  0,49 
8 170088 166976  3112  0,53 
9 212407 200358  12049      2,18  R 
10 221165 233739 -12574     -2,51  R 
* 
S = the square root of the mean square error 





R-sq(adj) = estimated adjusted R-square 
F-value =  the test statistic used to determine whether the term is associated with the response 
p-value =  determines whether the results are statistically significant 
t-value =  is a test statistic for t-tests that measures the difference between an observed sample 
statistic and its hypothesized population parameter in units of standard error 
VIF = Variance inflation factors measure how much the variance of the estimated regression 
coefficients are inflated as compared to when the predictor variables are not linearly related 
 
As a consequence, a further investigation of the regression was necessary. Because 
the deviations from linearity are sometimes difficult to detect, two additional 
graphical procedures were used for the right estimation of linearity:  
i) The first procedure plotted the residuals from the regression line versus 
the concentrations of vitamin B12 standard solutions (Fig. 4.40).   
 
Figure 4.40: Plot of residuals (from regression analysis) versus the concentrations 
of vitamin B12 (processed by statistical program MINITAB 17) 
 
ii) The second procedure plotted the residuals from the regression line 
versus the logarithm of the concentrations of vitamin B12 standard 





Figure 4.41: Plot of residuals (from regression analysis) versus the logarithm of the 
concentrations of vitamin B12 (processed by statistical program MINITAB 17) 
 
Based on the regulations of International Conference on Harmonization (ICH) in 
correlation with the two graphs above (Fig. 4.40 and Fig. 4.41), the residuals are not 
equally distributed between positive and negative values, from the concentration 
level of 0.4 – 0.7 μg/ ml, and the results of the regression analysis (Table 4.4 and 
Figure 4.41) indicated that concentration levels of 0.6 μg/ ml and 0.7 μg/ ml 
influenced negatively the adjustment of the linear regression line.  
 
Thus, it was decided to create a new calibration plot, including the concentrations of 
vitamin B12 from 0.01 – 0.30 μg/ ml. A six-point regression line was created from the 
following concentrations of the standard solutions of vitamin B12: 0.01, 0.025, 0.05, 
0.10, 0.20 and 0.30 μg/ ml (n=6). The following regression equation was found by 
plotting the peak area (y) versus the vitamin B12 concentration (x) expressed in μg/ 
ml:  
peak area = 81 + 325,621  vitamin  B12  μg/  ml) with R2 (adj) = 99.96 %.  
Whereas the intercept of the equation is 81 and the slope is 325,621. The 
demonstration of the coefficient R
2
 obtained from the regression line and 
demonstrates a satisfactory relationship between peak area and concentration of 
vitamin B12 (Fig. 4.42). The data obtained from linearity experiments are presented 







Figure 4.42: Graphical presentation of the linear regression line (0.01 – 0.30 μg/ ml)  
with the 95 % confidence interval and prediction interval 
 
Before a further examination of the regression, necessary was to obtain a diagnosis 
of the validity of the regression through the graph of Figure 4.43.  
 
Figure 4.43: Graphs for the estimation of the normality of residuals (produced by 
statistical program MINITAB 17) 
 
The Figure 4.43 shows that the graphs of normal plot and the histogram of the 
residuals are following the normal distribution in excellent way. It is observed that 





regression is independent of the actions of x values (concentration of vitamin B12) 
and the fitted values.  
By examining the results of Table 4.5 it is shown that with the absence of the 
concentrations 0.4 μg/ ml, 0.5 μg/ ml, 0.6 μg/ ml and 0.7 μg/ ml the accuracy of the 
regression line has improved significantly.  
 
Table 4.5: Regression analysis: Peak area versus vitamin B12 C (μg/ml) 
 
Analysis of Variance 





Regression 1 6894097598 6894097598 11894,41 0,000 
vitamin B12 μg/ l  1 6894097598 6894097598 11894,41 0,000 
Error 4 2318433 579608   
Total 5 6896416031    
Model Summary 
S 761,320     
R-sq 99,97 %     
R-sq(adj) 99,96 %     
R-sq(pred) 98,87 %     
Coefficients 
Term Coefficient Standard error 
coefficient 
T-Value P-Value VIF 
Constant 81 461 0,18 0,869  
vitamin B12 μg/ l  325621 2986 109,06 0,000 1,00 
Fits and Diagnostics for All Observations 
Observations Peak area      Fit    Residuals Standardized residuals 
1 3435 3407   28  0,00 
2 8077 8415 -338 -0,06 
3 15619 16760 -1141 -0,20 
4 33126 33451 -325 -0,05 
5 66212 66832 -620 -0,10 
6 97068 100213 -3145 -0,51 
 
The results presented in Table 4.5 demonstrated P value for the analysis of variance 
lower than 0.05, meaning that there is statistical significant linear regression (Fig. 
4.42) between the measured peak area and the concentration levels of vitamin B12. 
Thus, the R
2 
(adj) (adjusted= n<10) was improved to 99.97 %, meaning that the 
adjustment of the regression line was excellent. Thus, the method has an excellent 
linear range of concentrations from 0.01 μg/ ml until 0.30 μg/ ml, which covers from 






ICH defines the range of an analytical procedure as the interval from the upper to 
the lower concentration (amounts) of analyte in the sample (including these 
concentrations), in which has been demonstrated that the analytical procedure has a 
suitable level of precision, accuracy and linearity. For assay tests, ICH requires the 
minimum specified range to be 80 – 120 % of the test concentration147.  
 
In this study, the data obtained during the linearity and recovery studies were used 
to assess the range of the assay method. The precision data for this assessment was 
the precision of the three replicate samples, analyzed at tree different levels in the 
recovery studies. The valid analytical range of the method was the range of 
concentrations, which passed the linearity and accuracy criteria, and yields an RSD of 
< 2%. The linearity data described earlier demonstrates acceptable linearity for 
vitamin B12 over the range of 10 – 300 % of the target concentration. The RSD values 
obtained for the recovery of vitamin B12 at 30, 100, and 300 % of target are 0.85, 
0.70, and 0.72 %, respectively (Table 4.6). Each value was the result of three 
individual sample preparations and analysis. These data support a method range of 
30 – 300 % of the target concentration. 
4.6.2. Accuracy  
ICH defines the accuracy of an analytical procedure as the closeness of agreement 
between the conventional true value or an accepted reference value and the value 
found. Accuracy can also be described as the extent to which test results generated 
by the method and the true value agree
147
. Accuracy usually can be determined in 
one of four ways. 1
st
, accuracy can be assessed by analyzing a sample of known 
concentration (reference materials), and comparing the measured value with the 
true value. The 2
nd
 approach is to compare test results from the new method with 





 approach is based on the recovery of known amounts of analyte. 
This is performed by spiking analyte in blank matrices. For assay methods, spiked 
samples are prepared in triplicate at three levels over a range of 50-150% of the 
target concentration. The % recovery should then be calculated. Another technique 
which can also be used to determine the recovery of the spiked analyte is the 4
th
 
approach, the technique of standard additions. This approach is used if it is not 





 to collect data from a minimum of nine determinations 
over a minimum of three concentration levels covering the specified range (e.g., 
three concentrations, three replicates each). 
4.6.2.1. Estimation of Accuracy  
Taking all the conclusions from the recovery study (Chapter 4.3) under consideration 





matrix spiking method with defined analyte concentration (standard solution) was 
used for estimation of the recovery. Vitamin B12 was spiked to Hippophae 
rhamnoides powder samples, to vitamin B12 tablets, to liver (veal) and to Inula 
helenium, an amount of analyte underwent the same procedures without matrix 
(blank spike). The amounts of added analyte at the level of the target concentration 
(0.1 μg/ml) of our method. Hippophae rhamnoides samples were spiked at three 
concentration levels, the 1
st
 at the limit of quantification (LOQ), the 2
nd
 in the target 
concentration (0.1 μg/ml) and the 3rd at the upper limit of the linear range (0.3 μg/ 
ml). The following equation was used for the estimation of recovery from spiked 
samples:  
 
Recovery of spiked sample (%) = (Qfound – Qoriginal sample) * 100% 
                                                                   Qspiked   
Where, Qfound is the concentration in the sample with the addition of vitamin B12, 
Qoriginal sample is the concentration of a sample without any addition and Qspiked is the 
concentration of the added vitamin B12. The results of the recovery rate and the 
relative standard deviations of the measured samples are listed in Table 4.6. Blank 
spikes performed with the highest recovery (100 %) due to absence of matrix, the 
liver (veal) sample performed with 89 % recovery, whereas complex samples such as 
Hippophae rhamnoides and Inula helenium performed lower recoveries between 82 
– 90 %, due to matrix effects and the influence of homogenization process.  
 
Table 4.6: Precision and recovery data 
 
Samples Added amount of 
Vitamin B12 (μg/ ml) 








0.03 80 0.85 3 
0.10 90 0.70 3 
0.30 82 0.72 3 
Blank spike 0.17 100 0.67 3 
Elecampane (Inula helenium) 0.03 84 6.73 3 
Vitamin B12 tablets 0.12 80 0.89 3 





4.6.3. Specificity / Selectivity  
For the analysis of an active component of a pharmaceutical product, it is important 
to have a good knowledge of assay interference by possible degradants or synthesis 
precursors and assay interference by chemicals employed in sample preparation.  
In the present dissertation, the specificity of the method was studied with the 
comparison of the HPLC chromatogram of a blank sample, a spiked cranberry sample 
and the cranberry sample without spike (Fig. 4.44). From Figure 4.44 it becomes 
obvious that the vitamin B12 is well separated from any potential interference. 
Therefore, this method was specific for vitamin B12. 
 
Figure 4.44: HPLC-UV chromatograms of spiked cranberries sample (A), of 
cranberries sample (B) and a chromatogram of mobile phase (TFA 0.01% w/v) (C). 
The chromatographic conditions are described in chapter 4.2.4.1.  
 
4.6.4. Precision (System Repeatability, Method Repeatability and 
Intermediate Repeatability) 
Precision is the measure of the degree of repeatability of an analytical method under 
normal operation, and is normally expressed as the % RSD for a statistically 
significant number of samples. Precision may be performed at three different levels: 





4.6.4.1. System Repeatability 
The system repeatability studies the deviations of measurements under the same 
conditions and in the same measuring instrument. A precision criterion for an assay 
method is that the system repeatability R“D  ill e  1 %, and for the impurity 
assay, at the limit of quantitation, the instrument precision (repeatability) ill e   
%
139
. In this work, the system repeatability of the method was estimated by 36 
determinations with 6 replicate injections of a standard solution. Six different 
concentration levels of a standard solution were tested (0.010, 0.025, 0.050, 0.100, 
0.200 and 0.300 μg/ l  during the same day, under the same experimental 
conditions. The relative standard deviation (% RSD) of the analytes ranges from 7.37 
% (for lowest standard elution concentration) to 0.53 % (for the highest standard 
elution concentration) (Fig. 4.45).  
 
 
Figure 4.45: % Relative standard deviation (% RSD) of standard solution of 
cyanocobalamin in the concentration range of 0.01-2.00 μg/ml 
 
4.6.4.2. Method Repeatability 
Method repeatability (intra-day assay precision) is the results of the method 
operating over a short time interval under the same conditions (intra-assay 
precision). It should be determined from a minimum of six determinations at 100 % 




In this study, the method repeatability (intra-assay precision) was estimated by 
assaying 6 replicate samples from homogenous powder mixtures of Hippophae 


























same day, under the same experimental conditions. The relative standard deviation 
(% RSD) of the analyte (peak area) was 0.7 % and the relative standard deviation of 
the retention time of the analyte was 0.4 % as presented in Table 4.7.  
 
Table 4.7: Demonstration of method repeatability of the HPLC assay for vitamin B12 
as shown by the results of 6 replicate injections of Hippophae rhamnoides mixtures 
 
Injection number R.T (min) Peak area (mV s) 
1 4.157 29,122 
2 4.127 29,008 
3 4.153 29,105 
4 4.160 29,016 
5 4.113 28,900 
6 4.137 29,501 
Mean 4.141 29,108 
% RSD 0.452 0.714 
 
4.6.4.3. Intermediate Repeatability 
Intermediate precision (inter-day variation) is the results from within lab variations, 
due to random events, such as different days, analysts, equipment, etc. In 
determining intermediate repeatability, experimental design should be employed, so 
that the effects (if any) of the individual variables can be monitored. Precision 
criteria for an assay method is that the intra-assa  p e isio  ill e  2 %, and for 
impurity assay, at the li it of ua titatio , the i st u e t p e isio  ill e  5 %, 
and the intra-assa  p e isio  ill e  10 %139.  
 
In this study, intermediate precision (within-laboratory variation) was demonstrated 
by two operators, by analyzing the same powder mixtures of Hippophae rhamnoides, 
in the same HPLC system. The RSD values from all operators were in the range of 0.8 
% (n=2), less than 1%, and illustrated the good precision of the analytical method.  
4.6.5. Limit of Detection and Quantification 
The limit of detection (LOD) and limit of quantitation (LOQ) tests for the procedure 
are performed on samples containing very low concentrations of analyte. LOD is de-
fined as the lowest amount of analyte that can be detected above baseline noise; 










The limit of detection (LOD) and limit of the quantification (LOQ) of the method were 
calculated with the linear calibration curve method. This method is based on the 
standard deviation of response and slope. Hence LOD and LOQ can be expressed as 
LOD= 3.3 σ/ , a d LOQ=  σ/ , he e σ is the sta da d de iatio  of the espo se 
and b is the slope of the calibration curve (y=a+bx). The LOD of the method was 
0.004 μg/ ml and LOQ was 0.014 μg/ ml (Appendices 6.2.2.). 
 
Summary  
An HPLC assay for determining active ingredients in pharmaceutical products, and 
subsequent method validation, can be complex and time-consuming. However, a 
well-defined protocol and documented validation plan simplifies and shortens the 
process, while at the same time provides the regulatory agencies evidence that the 
analytical system and method is suitable for its intended use. This dissertation was 
intended to perform a method validation study, for the determination of vitamin B12 
in plant matrices, by generating both useful and meaningful data that meet all FDA, 
USP, and ICH validation requirements for pharmaceutical analysis. Vitamin B12 was 
quantified by an external 6-point calibration curve using cyanocobalamin solutions 
with concentrations between 0.01 – 0.3 μg/ ml. The calibration curve of pure 
solutions of vitamin B12 was linear (r
2
= 0.999), and the range of the analytical 
method included values between 30 – 300 % of the target concentration. The limit of 
detection was 0.004 μg/ ml and the limit of quantification was 0.014 μg/ ml, both 
were calculated with the linear calibration curve method. The repeatability of the 
method (0.7 % RSD) was determined by measuring vitamin B12 in Hippophae 
rhamnoides berries (n=6) that underwent the method protocol. The accuracy, which 
ranged between 80 – 100 %, was determined by adding vitamin B12 to homogeneous 
samples of Hippophae rhamnoides, blank spike, Elecampane (Inula helenium), 
vitamin B12 tablets and Liver (veal). For the sample of Hippophae rhamnoides three 
levels of vitamin B12 (0.03 μg/ml, 0.10 μg/ml and 0.30 μg/ml) were added               
and quantified performing a sample preparation, extraction, purification and 













4.7. Results and Discussion  
The vitamin B12 exists in free and bound form in food products. However, vitamin B12 
in plant samples can be found only in bound form. The optimized method caused the 
release of all bound vitamin B12 and enabled the quantitative chromatographic 
isolation of the vitamin B12. The extensive homogenization step, achieved to perfect 
the powder of solid samples such as Hippophae rhamnoides that due to insufficient 
homogenization, introduced significant deviations in vitamin B12 measurements and 
enhanced matrix effects. In addition, the application of the extensive 
homogenization step had a positive effect on vitamin B12 release in liquid samples 
(such as black mustard extract, Hippophaes rhamnoides juice, plant drugs 818,      
819, 822 and 823 from Teutopharma), contributing to a better stirring and 
homogenization of the sample. The choice of pH 7 was crucial for obtaining the 
highest values of vitamin B12. The results of HPLC showed significant amounts of 
vitamin B12 in several plant-based sources, with a maximum value of Hippophae 
rhamnoides plant containing 37.01 μg vitamin B12 / 100 g dry weight (Table 4.8). 
Some of the plants such as corn poppy (Papaver rhoeas) revealed traces of vitamin 
B12, however, the quantification was impossible because the signal of the peak was 
below the detection limit of the method.  
 
Table 4.8: Vitamin B12 concentration in different food sources* 
 
Plant-Based Solid Samples Vitamin B12 content (μg/ 100g) 
Hippophae rhamnoides 37.01 
Hippophae rhamnoides (analyzed in an external 
lab with AOAC 952.20/ 45.2.02 Method) 0.11 
Hippophae rhamnoides (analyzed in an external 
lab with Biacore Method) 0.08 
Hippophae rhamnoides Granulate 3.10 
Hippophae rhamnoides Extract (Bio-cultivation) 0.00 (Below LOD) 
Hippophae rhamnoides (Bio-cultivation) 4.58 
Elymus (dry extract) 23.10 
Elymus (grinded) 25.83 







Tab. 4.9 continued 
 
Cranberry 0.00 
Black salsify 0.00 
Parsnip (Pastinaka sativa) 0.00 
Corn poppy (Papaver Rhoeas) 0.00 
Garlic mustard (Alliaria petiolata) 0.00 
vitamin B12 tablets 9, .  .  μg/ Tablet) 
Liver (veal) 65.59 
Extracts Vitamin B12 content (μg/ 100g) 
Hippophae rhamnoides juice 0.10 
Black mustard (fluid) 1.52 
Plant drug 818 Teutopharma 26.28 
Plant drug 819 Teutopharma 25.06 
Plant drug 822 Teutopharma 17.98 
Plant drug 823 Teutopharma 13.26 
* all the values that are listed above (Table 4.8) are the measured amount of vitamin B12 by HPLC-














4.7.1. Vitamin B12 Tablets – Release Study 
The objective of this study was to evaluate retard tablets intended to release vitamin 
B12 (CN-Cobalamin) slowly, ideally within 4 h to release linear the total amount of the 
table. Two types of retard tablets were evaluated, 30 μg vitamin B12 / tablet and 50 
μg vitamin B12 / tablet. Both were diluted in various proportions of deionized water 
solutions at pH 2, mimicking stomach conditions and measured in various durations 
(0h, 1h, 2h, 4h and 8h) by the HPLC-UV gradient elution profile (C).  
 
The first experiment investigated the release time (h) of vitamin B12 from the tablet 
(30 μg vitamin B12 / tablet), diluted in 10 ml deionized water at pH 2. Replicate 
samples were measured and the results are plotted in Figure 4.46. Based on this 
dilution (V=10 ml) the expected final concentration is 3 μg/ ml vitamin B12. The 
results demonstrated a linear regression (y = 0,2978 x + 0,112, R² = 0,958) between 
the vitamin B12 and the release time during the first 4 hours. According to Figure 4.46 
the concentration of vitamin B12 remains stable after 4 h at 1.23 μg/ ml. Hence, the 
release of the vitamin B12 content was incomplete and only 41 % of the vitamin B12 
content of the table was released.  
 
 
Figure 4.46: Release kinetics plot of vitamin B12 tablets at 5 different durations (0h, 









The second study investigated the release of vitamin B12 from the tablets containing 
50 μg vitamin B12, in different dilution volumes: 
A) 20 ml 
B) 35 ml 
C) 50 ml 
in the same five durations (0h, 1h, 2h, 4h and 8h) in deionized water (pH 2) (Fig. 
4.47). The expected concentrations were A) 2.50 μg/ ml, B) 1.43 μg/ ml and C) 1.00 
μg/ ml, respectively.   
 
 
Figure 4.47: Release kinetics plot of vitamin B12 tablets at 5 different durations (0h, 
1h, 2h, 4h and 8h), diluted in A) 20 ml deionized water, B) 35 ml deionized water 
and C) 50 ml deionized water, all at pH 2 
 
According to Figure 4.47 the tablet diluted in 20 ml deionized water (A) released 
vitamin B12 content of 2.12 μg/ ml, meaning 85 % release of the total vitamin B12 
content. Even though, the plot (A) follows a linear curve for the first 4 h, after 8 h 
there is an unexpected increase of the vitamin B12 release. In 35 ml deionized water 
(B) the released vitamin B12 content reached 1.85 μg/ ml, which is in contrast to the 
expected final concentration of 1.43 μg/ ml. Probably the dilution was between 25 – 
30 ml deionized water. In 50 ml deionized water (C) the vitamin B12 release was at 
0.65 μg/ ml, namely 65 % of the total vitamin B12 amount.  
 
In conclusion, the dilution of the tablet in 20 ml deionized water (pH 2) contributed 






4.7.2. HPLC-MS/MS – Investigation of Vitamin B12 
Due to the fact that high amounts of biological inactive analogues of vitamin B12 
have been reported in other plant-based sources such as Spirulina, that can block 
vitamin B12 metabolism, it is essential to distinguish the real vitamin B12 from other 
vitamin B12 analogues (such as pseudo-vitamin B12) in the plant samples. The lower 
ligand of real vitamin B12, 5,6-dimethylbenzimidazole, is essential for the binding of 
the vitamin to the intrinsic factor for its absorption. Other inactive analogues of 
vitamin B12 have different lower ligands, e.g. pseudo-vitamin B12 has adenine as 
lower ligand. Microbiological assay (MBA), does not differentiate between active 
forms of vitamin B12 and other corrinoids, thus, an HPLC-MS/MS method was 
developed in order to measure the exact molecular mass of the measured vitamin 
B12 and distinguish the vitamin B12 forms.  
Before the development of the new gradient elution profile by HPLC-MS/MS, the 
basic forms of vitamin B12: CN-cobalamin, OH-cobalamin, adenosyl-cobalamin and 
methyl-cobalamin, were investigated relative to the retention time characteristics of 
their peak (Fig. 4.48), with fresh standard solutions by the optimized HPLC-UV 
gradient elution profile (C).  
 
Figure 4.48: A) Chromatogram of adenosyl-cobalamin standard solution, B) 
Chromatogram of cyano-cobalamin (vitamin B12) standard solution, C) 
Chromatogram of methyl-cobalamin standard solution, and D) Chromatogram of 










The gradient HPLC-UV profile (C) could separate the cyano-cobalamin (vitamin B12) 
from the other forms of vitamin B12, however, the same did not happen between the 
methy-cobalamin, adenosyl-cobalamin and hydroxo-cobalamin which disclosed the 
same retention time. An important observation was that all the standards had the 
same concentration (0.2 μg/ ml) but the size (peak area) and the shape of the peaks 
were different. That was expected, as the other forms of vitamin B12, apart from CN-
cobalamin, are sensitive to light and the losses of the vitamin came sooner. After 
using all the potentials of the HPLC-UV method for the characterization of vitamin 
B12 forms, it was decided to develop a more powerful detection profile with the use 
of mass spectrometry. 
Prior to HPLC-MS/MS method, a fraction collector was connected with the HPLC-UV  
apparatus, using the optimized elution profile (C), and gathered the vitamin B12 
fractions from Hippophae rhamnoides. Special attention was paid to gather only the 
peak of vitamin B12 without any of the co-eluted substances. A lot of fractions were 
gathered accumulative together and were kept in the freezer (- 80 
o
C) until further 
process. Then the fractions of vitamin B12 were dried under vacuum and 
reconstituted with 0.5 ml of 0.1 % formic acid (water solution). The final sample was 
analyzed by a new elution profile by HPLC-MS/MS (Appendices 6.1.2.5.). Based on 
the MS/MS spectra (Fig. 4.49), the corrinoid peak in Hippophae rhamnoides sample 
was confirmed as cyanocobalamin (vitamin B12), as the molecular mass of the 
corrinoid matches with vitamin B12 (m/z: 1,355.37). The Hippophae rhamnoides 
sample and standard solution of vitamin B12 have the same fragmentation profile 
(the ratio of m/z 678.5 to m/z 1,355.6 is equal in both spectra). Due to low 
concentrations of vitamin B12 in the present samples the analysis in MS was 
conducted in SIM (single ion mode) in order to increase the sensitivity of the 
method. The chromatogram in Figure 4.49 of the Hippophae rhamnoides sample 
o tai s also i o side a le peaks a d oise  at othe  ete tio  ti es hi h a  
indicate the presence of other corrinoids in Hippophae rhamnoides. To the best of 
our knowledge, the main form of cobalamins in Hippophae rhamnoides is vitamin 
B12.  
 
In conclusion, with 6.5 g dried Hippophae rhamnoides berries an individual can reach 
the recommended daily amount of vitamin B12 (2.4 μg/day). In addition, the 
concentration of Hippophae rhamnoides in vitamin B12 approaches nearly 74 % of 
vitamin B12 content of one of the richest natural sources of vitamin B12 such as pig 
liver (59.7 μg/ 100 g)37. The same sample was analysed via the commercial Biacore 














Figure 4.49: A) Chromatogram of cyanocobalamin (vitamin B12) standard solution 
(C=0.25 μg/ml), and HPLC-MS/MS spectra of an m/z [M+H]+ of 1,355 of 
cyanocobalamin (vitamin B12), B) Chromatogram of immunoaffinity purified extract 
of 558 (Hippophae rhamnoides), and HPLC-MS/MS spectra of an m/z [M+H]
+
 of 











5. Conclusions and Outlooks 
A new assay procedure was developed, evaluated and applied to determine the 
vitamin B12 content in a variety of plant samples. After the implementation of an 
extended homogenization procedure (mill homogenizer, morter and pestle, 
disperser and ultrasonic bath), the method was validated in-house and 
demonstrated good selectivity, good recovery rates of 80 - 100 %, and good 
repeatability (0.7 % RSD) for the accurate determination of vitamin B12 in complex 
matrices with a limit of detection of 0.004 μg/ ml. The immunoaffinity columns in 
conjunction with HPLC-UV gives the opportunity to quantify vitamin B12 in a range of 
matrices, from the simplest matrices such as vitamin tablets, to a juice to more 
complex food matrices and plant samples. Despite the general agreement that plants 
can not synthesize vitamin B12, actinorhizal plants such as Hippophae rhammnoides 
which are symbiotic with actinobacteria Frankia alni can cumulate amounts of 
vitamin B12. Taking into account that Frankia alni has a symbiotic relationship with 
many plants, the chances of finding vitamin B12 in other plants are significant. The 
development of the new HPLC-UV assay for the isolation and analysis of vitamin B12 
in a variety of samples (without depending on food origin, meaning animal-based 
source or plant-based source) in solid or liquid phase, in combination with the 
developed HPLC-MS/MS detection method, gives the opportunity to researchers not 
only to isolate and quantify vitamin B12 in a range of foods but also to identify the 
vitamin B12 forms. The forms can be investigated in terms of the nature of vitamin 
B12, namely, whether the sample contains real vitamin B12 or inactive analogues of 
cobalamin such as pseudo-vitamin B12 which are inactive in human beings. Based on 
our recent results Hippophae rhammnoides, Inula helenium, Elymus, Black Mustard 
(Brassica nigra), have shown satisfactory amounts of vitamin B12, and that raises 
















6.1. Methods and Protocols 
 
6.1.1. Initial Vitamin B12 Assay (protocol) 
Note: Vitamin B12 is sensitive to light. All operations were conducted under subdued 
light, use of amber glassware or covered tubes.  
 
6.1.1.1. Sample Preparation 
9-10 g of the sample was ground and homogenized to a fine powder with the use of 
mortar and pestle, combined with the use of liquid nitrogen until the powder of the 
sample to be homogenized (the best possible).  
 
6.1.1.2. Extraction of Vitamin B12 
Afterwards, an aliquot was accurately weighed and transferred into a flask.  
 60 ml of 50 mM acetate buffer (pH 4.0),  
 1 ml of KCN (1% w/v),  
 1 g pepsin  
 300 μl α-amylase 
were added, and the suspension was incubated at 37 
o
C for 3 h under agitation. The 
enzymatic reaction was stopped by incubating the sample in boiling water at 100 
o
C 
for 30-35 min. After cooling to room temperature, the solution was centrifuged at 
4,000 rpm for 25 min at 4 
o
C. The supernatant was collected and filtered through 
filter paper (589/2 Whatman, 90 mm). The solution was quantitatively transferred to 
a volumetric flask.  
 
Plant samples with high moisture content were cut into small particles in paper 
containers. The containers were placed in an incubator and dried at 90 
o
C for 24 h. 
The dry weights of the plant samples were derived by this procedures. All data also 
from fresh plant samples were corrected to dry weight.  
 
6.1.1.3. Purification and Concentration of Vitamin B12 
 Column preparation  
The immunoaffinity columns (IAC) (EASI-EXTRACT Vitamin B12, product code: R80B, 
R-BiopharmRhone Ltd., Darmstadt, Germany) were acclimated to ambient conditions 
 e o i g the  f o  the ef ige ato    i  efo e use. The IAC as attached 
to a vacuum glass syringe barrel, which was connected to a 15 ml falcon tube and 






 IAC purification  
After the removal of the buffer, 35-40 ml of the sample were applied to the column. 
The drain valve was set so as the flow rate to be approximately 2 ml/ min, a constant 
vacuum is guaranteed by the oil rotary pump. The application under pressure is 
important for the complete binding of the cyanocobalamin to the antibodies.  
 Column washing  
The column was washed with 10 ml deionized water in 2 ml portions, and then was 
completely dried by using enhanced air pressure. 
 Elution of vitamin B12 
The vitamin was eluted from the column, at a flow rate of 1 drop per second using 3 
ml of methanol (100 % HPLC grade) and collected. At that point backflushing is 
recommended, so as to increase contact time of solvent with the antibody gel, 
ensuring that the entire vitamin was eluted. 
 Evaporation of methanol 
The eluate was dried at 60 
o
C under reduced pressure and reconstituted in 500 μl of 
mobile phase (0.025% TFA) before HPLC-UV analysis was conducted. 
 
6.1.1.4. Analysis of Vitamin B12 (HPLC-UV) – Gradient profile (A) 
-Column: Kinetex C18 column (100 mm x 4.6 mm, 2.6 μm)  
-Pre-column: Kinetex C18 pre-column filter (4 mm x 3 mm ID) 
-Eluents:  
- Eluent A: 0.025% (w/v) trifluoroacetic acid (TFA) in water  
- Eluent B: pure acetonitrile  
 
Table 6.1: HPLC-UV gradient elution profile (A) 
 








- Column temperature: 30 °C 
- Flow rate: 0.5 ml /min 
- Wavelength of the UV detector: 361 nm 








6.1.1.5. Analysis of Vitamin B12 (HPLC-UV) – Gradient profile (Β) 
-Column: Kinetex C18 column (100 mm x 4.6 mm, 2.6 μm)  
-Pre-column: Kinetex C18 pre-column filter (4 mm x 3 mm ID) 
-Eluents:  
- Eluent A: 0.025% (w/v) trifluoroacetic acid (TFA) in water  
- Eluent B: pure acetonitrile  
 
Table 6.2: HPLC-UV gradient elution profile (B) 
 











- Column temperature: 30 °C 
- Flow rate: 0.5 ml /min 
- Wavelength of the UV detector: 361 nm 
- Injection volume: 100 μl 
 
6.1.2. Optimized Vitamin B12 Assay (protocol) 
Note: Vitamin B12 is sensitive to light. All operations were conducted under subdued 
light, use of amber glassware or covered tubes.  
 
6.1.2.1. Sample Preparation 
I) Solid samples. The sample (0.5-10 g, depending on the content of vitamin B12 in 
the sample) underwent an extended homogenization process: 
a. Mixer Mill, the sample (4 g in each container) was ground and homogenized 
to a fine powder, operating at 30 Hz for 2.5 min, and filling the jars with 55-60 
ml liquid nitrogen. 
b. Mortar and pestle (to perfect the fine sample). 
c. Disperser: the sample from (b) was diluted in 10 ml buffer (in a 50 ml Falcon 
tube) and processed with 24,000 rpm/ min, for 6 minutes. 
d. Ultrasonic bath: the Falcon tube with the dispersion after step C, was sunk 




II) Liquid samples. An aliquot of each sample (10-30 ml) was stirred well to ensure 
the homogeneity of the sample, and underwent only the steps C) and D) from the 
extended homogenization process, the rest of the process was proceeded as 
described in I). 
 
6.1.2.2. Extraction of Vitamin B12 
Afterwards, the aliquot  of 10 ml was accurately weighed and transferred into a flask.  
 50 ml of 50 mM acetate buffer (pH 4.0),  
 1 ml of KCN (1% w/v),  
 1 g pepsin  
 300 μl α-amylase 
were added, and the suspension was incubated at 37 
o
C for 1.5 h under agitation. 
The enzymatic reaction was stopped by incubating the sample in boiling water at 100 
o
C for 30 min. After cooling in an ice bath for 30 min, the solution was centrifuged at 
5,000 rpm for 25 min at 3 
o
C. The supernatant was collected and filtered through 
filter paper (589/2 Whatman, 90 mm). The pH was adjusted to pH 7 and the solution 
was quantitatively transferred to a volumetric flask and filled up to 100 ml with 
deionized H20.  
 
Plant samples with high moisture content were cut into small particles in paper 
containers. The containers were placed in an incubator and dried at 90 
o
C for 24 h. 
The dry weights of the plant samples were derived by this procedure. All data also 
from fresh plant samples were corrected to this dry weight.  
 
6.1.2.3. Purification and Concentration of Vitamin B12 
 Column preparation  
The immunoaffinity columns (IAC) (EASI-EXTRACT Vitamin B12, product code: R80B, 
R-BiopharmRhone Ltd., Darmstadt, Germany) were acclimated to ambient conditions 
 e o i g the  f o  the ef ige ato    i  efo e use. The IAC as atta hed 
to a vacuum glass syringe barrel, which was connected to a 15 ml falcon tube and 
the column storage buffer was removed with a flow rate of 2 ml/ min.  
 IAC purification  
A slow and steady flow rate is essential for the capture of the vitamin by the 
antibody. 20 ml of the sample were applied to the column (for optimal column 
performance the sample must be loaded onto the column containing a quantity of 
0.01 -0.05 μg vitamin B12. Do not exceed a quantity of 1.0 μg, as this is close to the 
capacity.) 
 Column washing  
The column was washed with 10 ml deionized water (5 ml/ min) and completely 





 Elution of vitamin B12 
The vitamin was eluted from the column, at a flow rate of 1 drop per second using 5 
ml of methanol (100 % HPLC grade) and collected. The elution efficiency of 5 ml 
methanol is above 96 %, larger volumes of methanol could not improve the elution 
efficiency. At that point backflushing is recommended, so as to increase contact time 
of solvent with the antibody gel, ensuring that the entire vitamin was eluted.  
 Evaporation of methanol 
The eluate was dried at 60 
o
C under reduced pressure and reconstituted in 500 μl of 
mobile phase (0.025% TFA) before HPLC-UV analysis was conducted. 
 
6.1.2.4. Analysis of Vitamin B12 (HPLC-UV) – Gradient profile (C) 
-Column: Kinetex C18 column (100 mm x 4.6 mm, 2.6 μm)  
-Pre-column: Kinetex C18 pre-column filter (4 mm x 3 mm ID) 
-Eluents:  
- Eluent A: 0.025% (w/v) trifluoroacetic acid (TFA) in water  
- Eluent B: pure acetonitrile  
 
Table 6.3: HPLC-UV gradient elution profile (C) 
 










- Column temperature: 30 °C 
- Flow rate: 1.0 ml/ min 
- Wavelength of the UV detector: 361 nm 
- Injection volume: 100 μl 
 
6.1.2.5. Analysis of Active forms of Vitamin B12 (HPLC-MS/MS gradient profile)  
-Column: C18 Pyramin (250 mm x 4 mm, 5 μm)  
-Eluents:  
- Eluent A: 0.1 % (w/v) formic acid (in water) 







Table 6.4: HPLC-MS/MS gradient elution profile  
 






- Ion source: ESI (+) 
- SIM width: 0.700 amu total 
- Detector is set a fixed voltage: 1200.00 volt 
- Syringe pump flow rate: 1.00 μl/ min 
- ESI needle voltage positive: +5000.00 
- ESI needle voltage negative: +600.00 
- Drying gas temperature: 350.00 
- API housing temperature: 50.00 
- Nebulizer gas pressure: 55.00 
- Drying gas pressure: 30.00 
- Flow rate: 0.3 ml /min 
- Wavelength of the UV detector: 361 nm 
- Scan range of m/z: 600 – 1600  
 
6.1.3. Determination of Moisture Content (protocol) – Gravimetric 
Method 
The determination of the moisture content of solid samples conducted following the 
above protocol:  
1. Labeling of the vials with a code for each sample. 
2. Drying of vials at 90 oC for 4 hours. 
3. Cool down the vials (in a desiccator) at room temperature for 1 hour. 
4. Careful weighing of the vials (4-digit analytical balance). 
5. Addition of sample to vials and weighing (sample + vials). 
6. Drying the samples+vials in an oven at 90 oC for 24 hours. 
7. Cool down samples+vials (in a desiccator) at room temperature for 1 hour. 
8. Careful weighing of samples+vials (4-digit analytical balance). 
9. Calculation of moisture content. 
The calculation of the moisture content was expressed in a fresh weight (FW) basis:  
 
% moisture(FW basis) = FW-DW  x 100 




However, the fresh weight (FW) basis was preferred, because tends to minimize 
changes in water content. The results from the analysed samples are listed below in 
Table 6.5.  
 
Table 6.5: % Moisture content of samples 
 
Sample codes Names % moisture content 
482 / 476 / 558 Hippophae rhamnoides 07.72 
483 / 477 Hippophae rhamnoides 06.63 
484 Hippophae rhamnoides 07.87 
485 - 11.61 
541 Celery powder 10.15 
543 Black salsify 8.16 
544 Parsnip (Pastinaka sativa) powder 11.22 
545 Elecampane (Inula helenium) 6.68 
546 Corn poppy (Papaver rhoeas) 12.59 
547 Garlic mustard (Alliaria petiolata) 09.04 
548 Sea buckthorn berries, organic 
farming Europe 
13.66 
549 Sea buckthorn berries, organic 
farming Europe 
08.65 
550 Sea buckthorn granule, Dr. 
Pandalis 
10.11 
551 Sea buckthorn extract, organic 
farming Europe 
08.73 
554 Sea buckthorn berries, organic 
farming Europe 
12.82 
556 - 06.13 
493 - 03.79 
818 - 0.00 
819  02.74 
820 Dry extract of European sort of 
couch grass radix (Agropyron 
repens) 
02.48 
821 Grinded European sort of couch 
grass radix (Agropyron repens) 
07.86 
823 - 0.63 
 Cranberries 13.29 
584 - 12.82 
 
6.2. Statistical Determinations 
6.2.1. Statistical Determination of the Incubation Time 
In order to compare the concentration of vitamin B12 in 3 three incubation times, 




sample was measured for the determination of vitamin B12 concentration. In order to 
test for the equality of means and to assess the differences between pairs of means, 
it was used one-way ANOVA with one factor (incubation time) with three levels (0.5, 
1.5 and 3.0 h). The results of the command ANOVA are shown in Table 6.6.  
 
Table 6.6: One-way ANOVA: Vitamin B12 co ce tratio  μg/  g  ersus 
Incubation time (h)  
 
Source                DF       SS MS       F P 
Incubation time (h)    2 1,3052   0,6526   10,19   0,046 
Error 3 0,1922   0,0641   
Total 5 1,4975    
S R-Sq R-Sq(adj)    
0,2531    87,16%    78,61%    
Level N Mean    StDev Individual 95% CIs For Mean Based on 
Pooled StDev 
Level  N    Mean   StDev    
 +---------+---------+---------+--------- 
 (--------*---------) 
                (--------*---------) 
                   (---------*--------) 
 +---------+---------+---------+--------- 
1,80      2,40      3,00      3,60 
0,5     2 2,3695   0,0827     
1,5     2 3,1815   0,3995            
3,0     2 3,4715   0,1605            
 
The p-value for the incubation time ANOVA is less than 0.05. This result indicates 
that the average differences between the incubation time and the concentration of 
vitamin B12 is statistically significant. Thus, some of the group means are different.  
 
For further investigation the Tukey comparison results to formally test whether the 
difference between a pair of groups is statistically significant. The Table 6.7 that 
includes the Tukey simultaneous confidence intervals show that the confidence 
interval for the difference between the incubation time 1.5 h and 3.0 h were 
overlapped. This indicates that the differences are not significant. 
 
Table 6.7: Grouping information using the Tukey method 
 
Incubation time (h)     N Mean   Grouping 
3,0          2 3,4715   A 
1,5          2 3,1815   A B 
0,5          2 2,3695         B 
Means that do not share a letter are significantly different. 
Tukey 95% Simultaneous Confidence Intervals All Pairwise Comparisons among Levels of 
Incubation time (h) 






Tab. 6.8: continued 
 
Incubation time (h) = 0,5 subtracted from: 
Incubation 
time (h) 
Lower Center Upper  
---+---------+---------+---------+----- 
            (---------*----------) 
              (----------*----------) 
---+---------+---------+---------+----- 
 -1,0       0,0       1,0       2,0 
 
1,5 -0,2458 0,8120 1,8698 
3,0 0,0442 1,1020 2,1598 
 
Incubation time (h) = 1,5 subtracted from: 
Incubation 
time (h) 
Lower Center Upper  
---+---------+---------+---------+----- 
      (---------*----------) 
---+---------+---------+---------+----- 
 -1,0       0,0       1,0       2,0 
3,0 -0,7678 0,2900 1,3478 
  
 
6.2.2. Statistical Determination of LOD and LOQ 
For the determination of the limit of detection (LOD) and the limit of quantification 
(LOQ), and in order to avoid subjective estimations such as the use of visual 
evaluation methods or not so accurate methods such as methods based on signal to 
noise (S/N) approach, the LOD and LOQ were calculated with the linear calibration 
u e ethod. A o di g to the fo ula: LOD= .  σ/ , a d LOQ=  σ/ , he e σ is 
the standard deviation of the response and b is the slope of the calibration curve 
(y=a+bx). However the σ can be expressed as  
I. The standard deviation of blank spike 
II. The residual standard deviation of the regression line 
III. The standard deviation of the y-intercepts of regression lines 
Based on fresh standard solutions of vitamin B12 a regression line was produced (see 
chapter 4.5.1.1. – Table 4.3 and Table 4.5) with the statistical program MINITAB 17 
resulting the following data:    
peak area = 81 + 325621 vitamin B12 μg/ ml) 
slope = 325621 
standard deviation of y-intercept = 461 
 
The LOD and LOQ were calculated based on the (iii) approach:  
LOD= (3.3 * 461)/ 325621=0.00467 => LOD = .  μg/ ml 








6.3. Samples - Ingredient List 
6.3.1. Vitamin B12 Tablets Ingredients (per 100 g) 
Microcrystalline cellulose, maltodextrin, L-glutamine (11.8%) 
Coating compositions: hydroxypropylmethylcellulose, sodium 
carboxymethylcellulose, hydroxypropylcellulose, L-serine (7.8%) 
Separating agent: magnesium salts of fatty acids, cyanocobalamin (vitamin B12 
0.006%) 
Excipient: mannitol, vegetable oil (coconut) 
Caking agent: talc, fatty acids 




































6.4.1. Reagents and Buffers 
 
Name                                                     Company, country 
Cyanocobalamin (vitamin B12)  pr. code: V2876, Sigma-Aldrich (Seelze, 
Germany) 
Hydroxocobalamin pr. code: H1428000, Sigma-Aldrich (Seelze, 
Germany) 
Methylcobalamin pr. code: M9756, Sigma-Aldrich (Seelze, 
Germany) 
Coenzyme B12 pr. code: C0884, Sigma-Aldrich (Seelze, 
Germany) 
Sodium acetate trihydrate  pr. code: 71188, Sigma-Aldrich (Seelze, 
Germany) 
Pepsin  pr. code: 77161, Sigma-Aldrich (Seelze, 
Germany) 
Trifluoroacetic acid (TFA)  pr. code: T6508  Sigma-Aldrich (Seelze, 
Germany) 
EDTA pr. code: 03682 Sigma-Aldrich (Seelze, 
Germany) 
L-carnosine pr. code: C9625 Sigma-Aldrich (Seelze, 
Germany) 
Copper(II) sulfate pentahydrate pr. code: C3036 Sigma-Aldrich (Seelze, 
Germany) 
Methanol (gradient grade for HPLC)  catalog. number 20864.320, VWR 
(Darmstadt, Germany) 
Acetonitrile (gradient grade for HPLC)  catalog number 20060.320 VWR 
(Darmstadt, Germany) 
Liquid nitrogen - , Linde (Pullach, Germany) 
Immunoaffinity columns pr. code: R80B, R-BiopharmRhone Ltd., 
Darmstadt, Germany)  
Stainzyme (α-amylase)  pr. code: NEN0019, Novozymes (Bagsværd, 
Denmark)  
Potassium cyanide  pr. code: 31252, Riedel-de Haën 
(Seelze, Germany) 
Ascorbic acid  Fluka Chemie GmbH (Buchs, Switzerland) 
Acetic acid  Sigma-Aldrich (Seelze, Germany) 
Sea buckthorn (Hippophae rhamnoides)Teutopharma (Glandorf, Germany) 
Black salsify Teutopharma (Glandorf, Germany) 




Elecampane (Inula helenium) Teutopharma (Glandorf, Germany) 
Corn poppy (Papaver rhoeas) Teutopharma (Glandorf, Germany) 
Garlic mustard (Alliaria petiolata)  Teutopharma (Glandorf, Germany) 
Sea buckthorn (Hippophae rhamnoides)  Naturix24 (Dransfeld, Germany) 
Sea buckthorn juice Alnavit (Bickenbach, Germany) 
Cranberry fruits Seeberger (Ulm, Germany) 
Liver (veal)  Wurst-Basar (Ronnenberg, Germany) 
Vitamin B12 tablets  Merz Pharma GmbH & Co. KGaA (Frankfurt 






































Apparatus                                                   Name, company           
Water purification system  Arium 611 system, Sartorius (Gottingen, 
Germany)  
Analytical balance TE412, Sartorius (Gottingen, Germany) 
Analytical balance TE2145, Sartorius (Gottingen, Germany) 
Analytical balance AC210S, Sartorius (Gottingen, Germany) 
Ice machine Ziegra Eismaschinen GmbH, (Isernhagen, 
Germany) 
Filter papers pr. code. 10300109, Whatman (Dassel, 
Germany) 
Pipettes  Eppendorf AG, (Hamburg, Germany) 
Centrifuge Tubes Corning BV Life Sciences, (Amsterdam, 
Netherland) 
Vacuum glass syringe barrel pr. code. No. 5-7044, Supelco (Deisenhofen, 
Germany) 
pH meter 766 Knick Elektronische Messgeräte GmbH 
& Co.KG, (Berlin, Germany) 
Freeze Dryer GAMMA 1-16 LSC plus Martin Christ GmbH, 
(Osterode, Germany) 
Mixer Mill  MM400, Retsch (Haan, Germany) 
Dispersion homogenizer Ultra-Turrax T-25, IKA (Staufen, Germany) 
Rotational vacuum concentrator system RVC 2-18, Christ (Harz, Germany) 
HPLC system Hitachi Chromaster, VWR-Hitachi, 
(Darmstadt, Germany) 
DAD-UV detector 5430 Diode Array detector, VWR-Hitachi, 
(Darmstadt, Germany) 
Auto-sampler  Hitachi Chromaster 5210, VWR-Hitachi, 
(Darmstadt, Germany) 
Pump  Varian 212 LC, (Darmstadt, Germany) 
UV-Vis detector  Varian Pro Star 325, (Darmstadt, Germany) 
TQ-MS mass spectrometer  Varian 320, (Darmstadt, Germany) 
Column  Eurospher 100-C18-5-HD, Macherey-Nagel, 
(Düren, Germany) 
Kinetex C18 column  Phenomenex, (Torrance, CA, USA) 
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